mymx_10q.htm

0001654954-22-011001.txt : 20220811 0001654954-22-011001.hdr.sgml : 20220811 20220811070411 ACCESSION NUMBER: 0001654954-22-011001 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 32 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220811 DATE AS OF CHANGE: 20220811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MYMETICS CORP CENTRAL INDEX KEY: 0000927761 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 251741849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-25132 FILM NUMBER: 221153626 BUSINESS ADDRESS: STREET 1: EUROPEAN EXECUTIVE OFFICE STREET 2: 4, ROUTE DE LA CORNICHE CITY: EPALINGES STATE: V8 ZIP: CH-1066 BUSINESS PHONE: 011-41-21-653-45-35 MAIL ADDRESS: STREET 1: EUROPEAN EXECUTIVE OFFICE STREET 2: 4, ROUTE DE LA CORNICHE CITY: EPALINGES STATE: V8 ZIP: CH-1066 FORMER COMPANY: FORMER CONFORMED NAME: ICHOR CORP DATE OF NAME CHANGE: 19970407 FORMER COMPANY: FORMER CONFORMED NAME: PDG REMEDIATION INC DATE OF NAME CHANGE: 19940801 10-Q 1 mymx_10q.htm FORM 10-Q mymx_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended June 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from __________ to _________

Commission file number: 000-25132

MYMETICS CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

25-1741849

State or Other jurisdiction of

Incorporation or Organization

I.R.S. Employer

Identification No.

c/o Ernie Stern

1101 Pennsylvania Avenue, N.W., Suite 300

Washington D.C.

United States

USA-20004

Address

Zip Code

c/o Mymetics SA

Route de la Corniche 4

Epalinges, Switzerland

CH-1066

Address of Principal Executive Offices

Zip Code

011 41 21 653 4535

Registrant’s Telephone Number, Including Area Code

Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Stock, Par Value $0.01 per share

MYMX

OTCQB venture stage marketplace

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large-accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large-accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large-accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

APPLICABLE ONLY TO CORPORATE ISSUERS

The number of shares outstanding of the Registrant’s Common Stock, $0.01 par value, was 303,757,622 as of August 11, 2022

PART I. FINANCIAL INFORMATION

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MYMETICS CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In Thousands of Euros, Except Share and Par Value)

	June 30,			December 31,
	2022			2021
	(unaudited)
ASSETS
Current Assets
Cash	€	350		€	571
Accounts receivable		54			15
Prepaid expenses		44			87
Total current assets		448			673

Rent deposit		10			10
Property and equipment, net of accumulated depreciation of €480 at June 30, 2022 and €474 at December 31, 2021		33			39
Right-of-Use Asset		186			239
Goodwill		6,671			6,671
	€	7,348		€	7,632

LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable	€	78		€	47
Deferred revenue		15			-
Operating Lease Liability		106			110
Non-convertible notes payable and related accrued interest to related parties		9,495			8,790
Convertible notes payable and related accrued interest to related parties		60,036			58,479
Total current liabilities		69,730			67,426

Long Term Liabilities
Debt-Principal Payable to the Federal Financing Bank		169			162
Operating lease liability		83			130
Total long-term liabilities		252			292
		69,982			67,718

Commitments and Contingencies (Note 3)		-			-

Shareholders' Deficit
Common stock, U.S. $0.01 par value; 1,200,000,000 shares authorized; issued and outstanding 303,757,622 at June 30, 2022 and at December 31, 2021		2,530			2,530
Preferred stock, U.S. $0.01 par value; 5,000,000 shares authorized; none-issued or outstanding		-			-
Additional paid-in capital		34,443			34,443
Accumulated deficit		(100,303	)		(97,750	)
Accumulated other comprehensive income		696			691
Total shareholders’ deficit		(62,634	)		(60,086	)
Total liabilities and shareholders’ deficit	€	7,348		€	7,632

The accompanying notes are an integral part of these condensed consolidated financial statements.

MYMETICS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(UNAUDITED)

(In Thousands of Euros, Except Per Share Data)

	For The Three Months Ended June 30,						For The Six Months Ended June 30,
	2022			2021			2022			2021

Revenue
Research and development	€	-		€	-		€	-		€	3
Grants		297			159			779			290
Other		-			-			3			-
		297			159			782			293
Expenses
Research and development		400			308			982			562
General and administrative		327			277			659			568
		727			585			1,641			1,130

Operating Loss		(430	)		(426	)		(859	)		(837	)

Interest expense		699			684			1,393			1,369
Other (income) expense		213			(22	)		301			100
Loss before income tax provision		(1,342	)		(1,088	)		(2,553	)		(2,306	)

Income tax provision		-			(14	)		-			(42	)
Net Loss		(1,342	)		(1,102	)		(2,553	)		(2,348	)

Other comprehensive income
Foreign currency translation adjustment		(2	)		1			5			(7	)
Comprehensive loss	€	(1,344	)	€	(1,101	)	€	(2,548	)	€	(2,355	)

Basic and dilutive earnings per share	€	(0.00	)	€	(0.00	)	€	(0.01	)	€	(0.01	)
Weighted-average shares outstanding, basic and diluted		303,757,622			303,757,622			303,757,622			303,757,622

The accompanying notes are an integral part of these condensed consolidated financial statements.

MYMETICS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

(UNAUDITED)

(In Thousands of Euros)

	Three and Six-month Period Ended June 30, 2021
	Common Stock Number of Par						Accumulated			Accumulated Other Comprehensive
	Shares		Value		APIC		deficit			Income			Total

Balance at December 31, 2020		303,757,622	E	2,530	E	34,443	E	(93,020	)	E	695		E	(55,352	)

Net loss		-		-		-		(1,246	)		-			(1,246	)
Translation adjustment		-		-		-		-			(8	)		(8	)
Balance at March 31, 2021		303,757,622	E	2,530	E	34,443	E	(94,266	)	E	687		E	(56,606	)

Net loss		-		-		-		(1,102	)		-			(1,102	)
Translation adjustment		-		-		-		-			1			1
Balance at June 30, 2021		303,757,622	E	2,530	E	34,443	E	(95,368	)	E	688		E	(57,707	)

	Three and six-month Period Ended June 30, 2022
	Common Stock Number of Par						Accumulated			Accumulated Other Comprehensive
	Shares		Value		APIC		deficit			Income			Total

Balance at December 31, 2021		303,757,622	E	2,530	E	34,443	E	(97,750	)	E	691		E	(60,086	)

Net loss		-		-		-		(1,211	)		-			(1,211	)
Translation adjustment		-		-		-		-			7			7
Balance at March 31, 2022		303,757,622	E	2,530	E	34,443	E	(98,961	)	E	698		E	(61,290	)

Net loss		-		-		-		(1,342	)		-			(1,342	)
Translation adjustment		-		-		-		-			(2	)		(2	)
Balance at June 30, 2022		303,757,622	E	2,530	E	34,443	E	(100,303	)	E	696		E	(62,634	)

The accompanying notes are an integral part of these condensed consolidated financial statements.

MYMETICS CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

(In Thousands of Euros)

	For The Six Months Ended			For The Six Months Ended
	June 30, 2022			June 30, 2021
Cash Flow from Operating Activities
Net loss	€	(2,553	)	€	(2,348	)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation		8			9
Changes in operating assets and liabilities
Receivables		(39	)		15
Accrued interest on convertible notes payable		1,557			1,370
Accrued interest on non-convertible notes payable		105			88
Accounts payable		31			(14	)
Deferred grant		15			36
Other		52			46
Net cash used in operating activities		(824	)		(798	)

Cash Flows from Investing Activities
Purchase of property and equipment		(2	)		(10	)
Net cash used in investing activities		(2	)		(10	)

Cash Flows from Financing Activities
Proceeds from borrowing on-line of credit with federal bank		-			-
Proceeds from issuance of non-convertible notes		600			-
Net cash provided by financing activities		600			-

Effect on foreign exchange rate on cash		5			(7	)
Net change in cash		(221	)		(815	)

Cash, beginning of period		571			1,083
Cash, end of period	€	350		€	268

Supplemental Disclosure of Cash Flow Information:
Cash paid for taxes		-			(38	)

The accompanying notes are an integral part of these condensed consolidated financial statements.

MYMETICS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022

(UNAUDITED)

Note 1. The Company and Summary of Significant Accounting Policies

BASIS OF PRESENTATION AND GOING CONCERN

The amounts in the notes are shown in thousands of EURO, unless otherwise noted, and rounded to the nearest thousand except for share and per share amounts.

The accompanying interim period condensed consolidated financial statements of Mymetics Corporation (the “Company”) set forth herein have been prepared by the Company pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosure normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such SEC rules and regulations. The interim period condensed consolidated financial statements should be read together with the audited financial statements and the accompanying notes included in the Company’s latest annual report on Form 10-K for the fiscal year ended December 31, 2021.

The accompanying financial statements of the Company are unaudited. However, in the opinion of the Company, the unaudited condensed consolidated financial statements contained herein contain all adjustments necessary to present a fair statement of the results of the interim periods presented. All adjustments made during the three and six-month period ending June 30, 2022 were of a normal and recurring nature.

The Company was created for the purpose of engaging in vaccine research and development. Its main research efforts in the beginning have been concentrated in the prevention and treatment of the AIDS virus and malaria. The Company has established a network which enables it to work with education centers, research centers, pharmaceutical laboratories and biotechnology companies. Besides the HIV and malaria vaccine candidates, the Company additionally has generated preclinical data for the following vaccines: Herpes Simplex and Respiratory Syncytial Virus (“RSV”), neither of which is currently being developed. The company also has clinical data for an intranasal influenza vaccine for the elderly which has finished a Phase I clinical trial and is currently on hold. As of June 30, 2022, the Company is working on several research projects for immunotherapy in the field oncology and for some infectious diseases with academic partners. Since April 2020, the Company has additionally started to work on the development of a intranasal virosome-based vaccine to prevent Covid-19, the disease caused by the SARS-CoV-2 virus. For the Covid-19 vaccine candidates, the Company is collaborating with leading academic institutions, such as Baylor College of Medicine in Texas, the Amsterdam Medical Center (AMC) of the University of Amsterdam in the Netherlands and the University Hospital in Bern, Switzerland.

As of June 30, 2022, the Company was engaged in the pre-clinical testing of some of its vaccine candidates, but a commercially viable product is not expected for several more years. However, the Company generated some revenue through collaboration and grant agreements.

These consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced negative cash flows from operations and significant losses since inception resulting in an accumulated deficit of €100,303 at June 30, 2022. Further, the Company’s current liabilities exceed its current assets by €69,282 as of June 30, 2022, and there is no assurance that cash will become available to pay current liabilities in the near term. Management is seeking additional financing but there can be no assurance that management will be successful in any of those efforts. These conditions raise substantial doubt about our ability to continue as a going concern within one year from the issuance of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

LEASES

Effective January 1, 2019, the Company adopted ASC 842, which established a right-of-use (“ROU”) model requiring lessees to record a right-of-use (“ROU”) asset and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease, the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding right-of- use (“ROU”) asset. Lease liabilities represent the present value of our future lease payments over the expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company’s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.

IMPACT OF THE NOVEL CORONAVIRUS

On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus originating in Wuhan, China (the “COVID-19 outbreak”) and the risks to the international community as the virus spreads globally beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally.

The COVID-19 pandemic has continued to evolve. Although at this date the restrictive measures and impacts are reduced due to the role out of vaccination programs, the extent to which the outbreak impacts our business, preclinical studies and clinical trials will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, the duration of the pandemic, travel restrictions and social distancing, business closures or business disruptions and the effectiveness of actions taken in the U.S., Europe, and other countries to contain and treat the disease. As such, it is uncertain as to the full magnitude that the pandemic will have on the Company’s financial condition, liquidity, and future results of operations.

Management has taken measures in-line with the country requirements where we are operating, and we are actively monitoring the global situation on its financial condition, liquidity, operations, scientific collaborations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2022.

The Company is dependent on its workforce to deliver and advance its research. Developments such as physical distancing and working from home directives have and will continue to impact the Company’s ability to deploy its workforce effectively. While restrictions are being lifted across the world, prolonged workforce disruptions may negatively impact future revenues for the remainder of fiscal year 2022 and the Company’s overall liquidity.

The Company is dependent on its partners in certain projects, such as the University of Louisiana at Lafayette (“ULL”) for the NIH funded project to maintain the agreed timelines and execute their tasks. Developments such as social distancing and shelter-in-place directives and lock-down directives have and will continue to impact the Company’s ability to execute on project plans and research objectives effectively. While expected to be temporary, prolonged disruptions in collaboration projects may negatively impact funding for the fiscal year 2022 and the Company’s overall liquidity.

Although the Company cannot estimate the length or gravity of the impact of the COVID-19 outbreak at this time, if the pandemic continues, it may have a material adverse effect on the Company’s results of future operations, financial position, and liquidity for the fiscal year 2022.

CORONAVIRUS AID, RELIEF AND ECONOMIC SECURITY ACT

On March 27, 2020, the U.S. Government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into law. The CARES Act includes various income and payroll tax provisions. The Company has analyzed the tax provisions of the CARES Act and determined they have no significant financial impact to the condensed financial statements. The Company has no intention of taking advantage of other benefits provided by the CARES Act but will continue to evaluate the impact on the Company’s financial position.

PRINCIPLES OF CONSOLIDATION

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. Significant intercompany accounts and transactions have been eliminated.

NEW ACCOUNTING PRONOUNCEMENT

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. Specifically, ASU 2020-06 simplifies accounting for the issuance of convertible instruments by removing major separation models required under current GAAP. In addition, the ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and simplifies the diluted earnings per share (EPS) calculation in certain areas. ASU 2020-06 will be effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, beginning in fiscal years which begin after December 15, 2020. The FASB has specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company is currently evaluating the impact of the pending adoption of this new standard on its consolidated financial statements.

FOREIGN CURRENCY TRANSLATION

The Company translates non-Euro assets and liabilities of its subsidiaries at the rate of exchange at the balance sheet date. Revenues and expenses are translated at the average rate of exchange throughout the period. Unrealized gains or losses from these translations are reported as a separate component of comprehensive income. Transaction gains or losses are included in foreign exchange (gain) loss in the consolidated statements of comprehensive loss. The translation adjustments do not recognize the effect of income tax because the Company expects to reinvest the amounts indefinitely in operations. The Company’s reporting currency is the Euro because substantially all of the Company’s activities are conducted in Europe.

CASH

The Company consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents. Cash deposits are occasionally in excess of insured amounts.

REVENUE RECOGNITION

Effective January 1, 2018, the Company adopted Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers, using the modified retrospective method and there was no impact to financial position and results of operations as a result of the adoption. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under Topic 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of Topic 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Overall, adoption of the new standard did not result in an adjustment to amounts previously reported in our consolidated financial statements and there were no other significant changes impacting the timing or measurement of our revenue or our business processes and controls.

The Company has concluded that government grants are not within the scope of Topic 606, as they do not meet the definition of a contract with a “customer”. The Company concluded the definition of a contract with a “customer” was not met as the counterparty to the government grants has not contracted to obtain goods or services and thus the contracts are not considered to have commercial substance. Government grants provide the Company with payments for certain types of expenditures related to research and development activities over a contractually defined period. Revenue from government grants is recognized in the period during which the related costs are incurred, provided that the applicable conditions under the government contracts have been met.

NIH

On April 29, 2019, the National Institutes of Health (“NIH”) awarded the Company and Texas Biomedical Research Institute (“Texas Biomed”) a five-year grant for the project called “Cold Chain-independent, Needle-free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels” (“NIH Grant”). The project started on May 1, 2019 and is planned for five years. It was initially co-led by Texas Biomed, but due to the move of Dr. Ruth Ruprecht, the Co-Principal Investigator, to the University of Louisiana at Lafayette (“ULL”) at the end of 2019, ULL has become the co-lead with Mymetics for this project. The overall budget related to the project is US$8,850 with US$1,940 approved for the first year, US$1,856 approved for the second year, and US$1,720 for the third year. In April 2022, the Company filed a report to the NIH in collaboration with ULL, to validate funds for the fifth year of the ongoing HIV project (May 2022 to April 2023). The funds for the fourth year were approved in May 2022 with a total budget of US$ 1,616.

The amounts mentioned in the following statements are purely related to the Company and not to the other partners in the project: The overall portion of the grant allocated to the Company is US$5,930, with US$1,190 approved for the first year, US$1,052 for the second year, US$ 1,078 for the third year and US$1,328 approved in June 2022 for the fourth year.

The cost incurred and granted under the sub-award with Texas Biomed for the period of May to December 2019 was US$547 (€542). The sub-award contract between ULL and the Company for the period of January 2020 to April 2021, was signed for a total budget of US$870 and US$1,078 for the period May 2021 to April 2022. The total grant revenue incurred as of today is US$2,666 (€2,527), of which US$842 (€779) has been incurred during the six-months ended June 30, 2022. First results are expected to be reported in 2023.

The project has the objective to prepare the Company’s promising HIV-1 vaccine candidate for clinical trials, by first executing a non-human primate (“NHP”) study, where the test subjects will be receiving Mymetics’ virosome based HIV-1 vaccine candidate by several intra-muscular and intra-nasal applications, followed by rectal challenges. As of June 30, 2022, Mymetics has successfully produced five sets of virosome based vaccines and the NHPs have received two intramuscular vaccinations and three intranasal vaccinations in two different studies. The vaccinations were well tolerated. These studies are ongoing. The vaccine is created to induce protective mucosal antibodies acting as a frontline defense against sexual HIV transmission. This awarded grant from the NIH will allow the Company to continue some of the developments that were achieved during the European Horizon 2020 project.

In February 2022, Mymetics announced the publication of results in Frontiers in Immunology with title: “Cooperation between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques against Mucosal SHIV challenges”.

Option to License Agreement – ANERGIS SA

In April 2018 Mymetics engaged in a Research and Option to License Agreement with Anergis SA. Under the agreement, a mice proof-of-concept immunogenicity study evaluated the effects of the Bet v 1 COPs (Anergis’ proprietary birch pollen allergy peptides) using the five subcutaneous injection schedules used in former AllerT clinical trials. The development of AllerT (Bet v 1 COPs plus aluminum hydroxide) was discontinued by Anergis in 2017 following completion of a Phase 2 clinical trial showing evidence of sensitization to the peptides and a 7% reduction in seasonal allergy symptoms vs placebo (p=0.0047). In the mice study, AllerT was compared to Bet v 1 COPs linked to Mymetics’ virosomes (the “Bet v 1 COP-virosomes”).

In December 2018 Anergis and Mymetics reported that the administration of AllerT led to the development of Bet v 1 specific IgEs (p<0.001) associated with a more pronounced TH2 than TH1 response. In contrast, in the mice receiving the Bet v 1 COP-virosomes, no development of Bet v 1 specific IgEs were observed (p<0.001 vs AllerT). With the same dose of Bet v 1 COPs, there was a strong boost of immunogenicity with a TH1 antibody response, which was a hundred times greater than with aluminum hydroxide (p<0.001). The Bet v 1 COP-virosomes were well tolerated. The success criteria were met and Anergis had a time limited option to enter into an exclusive license agreement with Mymetics for the use of virosomes in the field of allergies.

In October 2019, Mymetics announced that Anergis SA started a new study with Stallergenes Greer SA whereby the COP-Virosomes were tested in the therapeutic mouse model of birch allergy in comparison with positive controls, i.e., birch allergen and birch pollen extract. This model has been confirmed as having predictive value towards the future clinical efficacy of new AIT treatment candidates.

In May 2020, Mymetics announced the results of the study with Stallergenes Greer, a worldwide leader in allergen immunotherapy (AIT) and Anergis, a leader in ultra-fast AIT research and development. The results showed that a treatment with COP-virosomes was able to cure allergic asthma in birch pollen sensitized mice and that the COP-virosomes were significantly superior to the COP or the virosome alone, confirming the synergy between COP and virosomes to foster an improved second-generation AIT treatment.

In January 2021, following the two successful studies with its virosome platform, Mymetics announced the acceptance of its joint publication in the scientific journal Clinical & Experimental Allergy with Stallergenes Greer SA and Anergis SA, with the title: Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice.

As of February 1, 2021, Anergis SA has entered into liquidation since it was not able to raise sufficient funds to continue to operate. As of June 17, 2022, Anergis SA has entered into bankruptcy proceedings.

RECEIVABLES

Receivables are stated at their outstanding principal balances. Management reviews the collectability of receivables on a periodic basis and determines the appropriate amount of any allowance. There was no allowance necessary at June 30, 2022 or December 31, 2021. The Company writes off receivables to the allowance when management determines that a receivable is not collectible. The Company may retain a security interest in the products sold.

PROPERTY AND EQUIPMENT

Property and equipment is recorded at cost and is depreciated over its estimated useful life on straight-line basis from the date placed in service. Estimated useful lives are usually taken as three years.

IMPAIRMENT OF LONG-LIVED ASSETS

Long-lived assets, which include property and equipment, are assessed for impairment whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. The impairment testing involves comparing the carrying amount to the forecasted undiscounted future cash flows generated by that asset. In the event the carrying value of the assets exceeds the undiscounted future cash flows generated by that asset and the carrying value is not considered recoverable, impairment exists. An impairment loss is measured as the excess of the asset’s carrying value over its fair value, calculated using a discounted future cash flow method. An impairment loss would be recognized in net income (loss) in the period that the impairment occurs.

GOODWILL

Goodwill represents the excess of purchase price over the value assigned to the net tangible and identifiable intangible assets of a business acquired. The Company typically performs its annual goodwill impairment test effective as of April 1 of each year, unless events or circumstances indicate impairment may have occurred before that time. The Company assesses qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. After assessing qualitative factors, the Company determined that no further testing was necessary. If further testing was necessary, the Company would determine the fair value of each reporting unit and compare the fair value to the reporting unit’s carrying amount. The Company has one reporting unit.

RESEARCH AND DEVELOPMENT

Research and development costs are expensed as incurred.

WITHHOLDING TAXES

On March 10, 2021, the Swiss Federal tax administration conducted a withholding tax audit on Mymetics SA’s financial statements for the years 2015 to 2019. At the end of the tax audit, the tax inspector concluded that a portion of the intercompany interest expenses related to the subordinated loan from Mymetics Corporation to Mymetics SA could be considered as a hidden dividend distribution and therefore subject to Swiss withholding tax. The tax inspector encouraged the Company to file the relevant Swiss withholding tax forms to benefit from the double tax treaty between Switzerland and the United States. All required documentation has been sent, assessed and approved by the Swiss Federal tax administration. The portion of the intercompany interest expenses related to the subordinated loan from Mymetics Corporation to Mymetics SA is considered as a hidden dividend distribution and therefore subject to Swiss withholding tax at a reduced tax rate of 5% and based on the double tax treaty in force between Switzerland and the United State of America. All required tax declaration forms have been filed and the related withholding tax amounts have been accounted for as of December 31, 2021.

TAXES ON INCOME

The Company accounts for income taxes under an asset and liability approach that requires the recognition of deferred tax assets and liabilities for expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. In estimating future tax consequences, the Company generally considers all expected future events other than enactments of changes in the tax laws or rates.

The Company reports a liability, if any, for unrecognized tax benefits resulting from uncertain income tax positions taken or expected to be taken in an income tax return. Estimated interest and penalties, if any, are recorded as a component of interest expense and other expense, respectively.

The Company has not recorded any liabilities for uncertain tax positions or any related interest and penalties at June 30, 2022 nor December 31, 2021. The Company’s United States tax returns are open to audit for the years ended December 31, 2015 to 2019. The returns for the Swiss subsidiary, Mymetics S.A., are open to audit for the year ended December 31, 2021. The returns for the Netherlands subsidiaries, Bestewil B.V. and Mymetics B.V., are open to audit for the year ended December 31, 2021.

EARNINGS PER SHARE

Basic earnings per share is computed by dividing net income or loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. Diluted earnings per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities. For the periods ended June 30, 2022 and 2021, options and convertible debt were not included in the computation of diluted earnings per share because their effect would be anti-dilutive due to net losses incurred under the treasury stock method.

For the three and six months ended June 30, 2022, the basic weighted and diluted average number of shares was 303,757,622. The total potential number of shares issuable of 784,480,472 at June 30, 2022 includes 758,730,472 potential issuable shares related to convertible loans, and 25,750,000 potential issuable shares related to outstanding stock options granted to employees.

For the three and six months ended June 30, 2021, the basic weighted and diluted average number of shares was 303,757,622. The total potential number of shares issuable of 747,880,794 at June 30, 2021 includes 722,130,794 potential issuable shares related to convertible loans, and 25,750,000 potential issuable shares related to outstanding stock options granted to employees.

PREFERRED STOCK

The Company has authorized 5,000,000 shares of preferred stock that may be issued in several series with varying dividend, conversion and voting rights. No preferred shares are issued or outstanding at June 30, 2022 or December 31, 2021.

ESTIMATES

The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

FAIR VALUE MEASUREMENTS

Fair value guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include:

Level 1-

Quoted prices in active markets for identical assets or liabilities.

Level 2-

Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated byobservable market data for substantially the full term of the assets or liabilities.

Level 3-

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the

assets or liabilities.

FAIR VALUES OF FINANCIAL INSTRUMENTS

The Company generally has the following financial instruments: cash, receivables, accounts payable, and notes payable. The carrying value of cash, accounts receivable, and accounts payable, approximates their fair value based on the short-term nature of these financial instruments. Management believes the fair value of the note’s payable is reflecting the actual value reported for these instruments.

CONCENTRATIONS

The Company derived 100% and 99% of grant revenue for the six-month periods ended June 30, 2022 and 2021, from one grantor, respectively. For the period ended December 31, 2021, the Company derived 99% of grant revenue from one partner.

RELATED PARTY TRANSACTIONS

Mr. Ernest M. Stern, the Company’s outside U.S. counsel, is both a director of the Company and is a partner in Culhane Meadows PLLC, the firm retained as legal counsel by the Company. The Company incurred professional fees to the counsel’s law firms totaling €27 and €3 for the three months ended June 30, 2022 and 2021 respectively; and €33 and €14 for the six months ended June 30, 2022 and 2021, respectively.

Two of the Company’s major shareholders have granted secured convertible notes and short-term convertible notes and promissory notes, which have a total carrying amount of €69,073 including interest due as of June 30, 2022. Conversion prices on the Euro-denominated convertible debt have been fixed to a fixed Euro/US dollar exchange rate.

Note 2. Debt Financing

Certain principal shareholders have granted the Company secured convertible notes (in accordance with the Uniform Commercial Code in the State of Delaware), short term convertible notes and other short-term notes, which have a total carrying value of €69,531 including interest due to date. Interest incurred on these notes since inception has been added to the principal amounts.

The details of the convertible notes and loans are as follows at June 30, 2022:

									Fixed
								Conversion	Rate
Lender	1st-Issue	Principal		Duration		Interest		Price	EUR/USD
Price	Date	Amount		(Note)		Rate		(stated)	Conversion

Eardley Holding A.G. (1)	06/23/2006	€	182	(2	)	10% pa	$	0.10	N/A
Anglo Irish Bank S.A.(3)	10/21/2007	€	500	(2	)	10% pa	$	0.50	1.4090
Round Enterprises Ltd.	12/10/2007	€	1,500	(2	)	10% pa	$	0.50	1.4429
Round Enterprises Ltd.	01/22/2008	€	1,500	(2	)	10% pa	$	0.50	1.4629
Round Enterprises Ltd.	04/25/2008	€	2,000	(2	)	10% pa	$	0.50	1.5889
Round Enterprises Ltd.	06/30/2008	€	1,500	(2	)	10% pa	$	0.50	1.5380
Round Enterprises Ltd.	11/18/2008	€	1,200	(2	)	10% pa	$	0.50	1.2650
Round Enterprises Ltd.	02/09/2009	€	1,500	(2	)	10% pa	$	0.50	1.2940
Round Enterprises Ltd.	06/15/2009	€	5,500	(2,4	)	10% pa	$	0.80	1.4045
Eardley Holding A.G.	06/15/2009	€	100	(2,4	)	10% pa	$	0.80	1.4300
Von Meyenburg	08/03/2009	€	200	(2	)	10% pa	$	0.80	1.4400
Round Enterprises Ltd.	10/13/2009	€	2,000	(2	)	5% pa	$	0.25	1.4854
Round Enterprises Ltd.	12/18/2009	€	2,200	(2	)	5% pa	$	0.25	1.4338
Round Enterprises Ltd.	08/04/2011	€	1,148	(5,6	)	10% pa	$	0.034	N/A
Eardley Holding A.G.	08/04/2011	€	297	(5,6	)	10% pa	$	0.034	N/A
Round Enterprises Ltd.	11/08/2011	€	400	(6	)	10% pa	$	0.034	1.3787
Eardley Holding A.G.	11/08/2011	€	100	(6	)	10% pa	$	0.034	1.3787
Round Enterprises Ltd.	02/10/2012	€	1,000	(6	)	10% pa	$	0.034	1.3260
Eardley Holding A.G.	02/14/2012	€	200	(6	)	10% pa	$	0.034	1.3260
Round Enterprises Ltd.	04/19/2012	€	322	(6	)	10% pa	$	0.034	1.3100
Eardley Holding A.G.	04/19/2012	€	80	(6	)	10% pa	$	0.034	1.3100
Round Enterprises Ltd.	05/04/2012	€	480	(6	)	10% pa	$	0.034	1.3152
Eardley Holding A.G.	05/04/2012	€	120	(6	)	10% pa	$	0.034	1.3152
Round Enterprises Ltd.	09/03/2012	€	200	(6	)	10% pa	$	0.034	1.2576
Eardley Holding A.G.	09/03/2012	€	50	(6	)	10% pa	$	0.034	1.2576
Round Enterprises Ltd.	11/14/2012	€	500	(6	)	10% pa	$	0.034	1.2718
Eardley Holding A.G.	12/06/2012	€	125	(6	)	10% pa	$	0.034	1.3070
Round Enterprises Ltd.	01/16/2013	€	240	(6	)	10% pa	$	0.034	1.3318
Eardley Holding A.G.	01/16/2013	€	60	(6	)	10% pa	$	0.034	1.3318
Round Enterprises Ltd.	03/25/2013	€	400	(6	)	10% pa	$	0.037	1.2915
Eardley Holding A.G.	04/14/2013	€	150	(6	)	10% pa	$	0.034	1.3056
Round Enterprises Ltd.	04/14/2013	€	600	(6	)	10% pa	$	0.034	1.3056
Eardley Holding A.G.	05/15/2013	€	170	(6	)	10% pa	$	0.037	1.2938
Round Enterprises Ltd.	05/15/2013	€	680	(6	)	10% pa	$	0.037	1.2938
Eardley Holding A.G.	06/24/2013	€	60	(6	)	10% pa	$	0.025	1.3340
Round Enterprises Ltd.	06/24/2013	€	240	(6	)	10% pa	$	0.025	1.3340
Eardley Holding A.G.	08/05/2013	€	80	(6	)	10% pa	$	0.018	1.3283
Round Enterprises Ltd.	08/05/2013	€	320	(6	)	10% pa	$	0.018	1.3283
Eardley Holding A.G.	03/01/2017	€	230	(7	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	03/01/2017	€	920	(7	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	10/18/2017	€	230	(7	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	10/18/2017	€	920	(7	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	06/01/2018	€	160	(8	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	06/01/2018	€	640	(8	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	11/10/2018	€	160	(8	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	11/10/2018	€	640	(8	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	06/15/2019	€	120	(9	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	06/15/2019	€	480	(9	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	12/20/2019	€	120	(10	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	12/20/2019	€	480	(10	)	2.5% pa		N/A	N/A
Eardley Holding AG	06/15/2020	€	220	(11	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	06/15/2020	€	880	(11	)	2.5% pa		N/A	N/A
Eardley Holding AG	12/15/2020	€	170	(12	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	12/15/2020	€	680	(12	)	2.5% pa		N/A	N/A
Eardley Holding AG	08/15/2021	€	240	(13	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	08/15/2021	€	960	(13	)	2.5% pa		N/A	N/A
Eardley Holding AG	04/30/2022	€	120	(14	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	04/30/2022	€	480	(14	)	2.5% pa		N/A	N/A
Total Short Term Principal Amounts		€	36,744
Accrued Interest		€	32,787
TOTAL LOANS AND NOTES		€	69,531

(1) Private investment company of Dr. Thomas Staehelin, member of the Board of Directors and of the Audit Committee of the Company. Face value is stated in U.S. dollars at $190.

(2) This maturity date is automatically prolonged for periods of three months, unless called for repayment.

(3) Renamed Hyposwiss Private Bank Genève S.A. and acting on behalf of Round Enterprises Ltd. which is a major shareholder.

(4) The loan is secured against 2/3rds of the IP assets of Bestewil Holding BV and against all property of the Company.

(5) The face values of the loans are stated in U.S. dollars at $1,200 and $300, respectively.

(6) This maturity date is automatically prolonged for periods of three months, unless called for repayment. The conversion price per share is determined by the lower of (i) reducing by 10% the price per share of the Company’s common stock paid by the investors in connection with an investment in the Company of not less than US$20,000, or (ii) at the fixed conversion price using a fixed exchange rate which are noted in the table above. The convertible note holder has the right to convert at any time prior to the maturity date, at the convertible note holder’s option, prior to the repayment of the outstanding balance under the note by the Company, to convert the unpaid outstanding principal balance and accrued interest, in whole or in part, into common stock at the fixed conversion price as stated in the contract.

(7) On March 1, 2017, Round Enterprises Ltd. and Eardley Holding AG each provided two promissory Notes for a total of €1,840 and €460, respectively, with a 2.5% interest per annum and a maturity date of March 1, 2018. The first 50% of the promissory Notes of €920 and €230, respectively, were provided immediately. The second 50% of the promissory notes of €920 and €230, respectively, were provided on October 18, 2017, with a 2.5% interest per annum and a maturity date of October 18, 2018. Both Round Enterprises Ltd. And Eardley Holding AG have agreed to amend the maturity date of these promissory notes to follow the same terms of the other convertible loans. Therefore, the maturity date of the promissory notes is amended to be the later of (i) June 30, 2018, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. The amendments were accounted for as modifications in the consolidated financial statements.

(8) On June 1, 2018, Round Enterprises Ltd. and Eardley Holding AG each provided two promissory Notes for a total of €1,280 and €320 in two tranches, respectively, with a 2.5% interest per annum. The first tranche of the promissory Notes of €640 and €160, respectively, were provided immediately. The second tranche of the promissory notes of €640 and €160, respectively, were provided on November 10, 2018, with a 2.5% interest per annum. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2019, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

(9) On June 15, 2019, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €600 with a 2.5% interest per annum. The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

(10) On December 20, 2019, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €600 with a 2.5% interest per annum. The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

(11) On June 15, 2020, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €1,100 with a 2.5% interest per annum. The promissory Notes of €880 and €220, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

(12) On December 15, 2020, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €850 with a 2.5% interest per annum. The promissory Notes of €680 and €170, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) March 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

(13) On August 15, 2021, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €1,200 with a 2.5% interest per annum. The promissory Notes of €960 and €240, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

(14) On April 30, 2022, Round Enterprises Ltd. and Eardley Holding AG each provided two promissory Notes for a total of €960 and €240 in two tranches, respectively, with a 2.5% interest per annum. The first tranche of the promissory Notes of €480 and €120, respectively, were provided immediately. The second tranche of the promissory notes of €480 and €120, respectively, will be provided in August, 2022, with a 2.5% interest per annum. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2022, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

On April 2, 2020, the Swiss entity, Mymetics SA, received a federal credit line of Chf168 (€156) in relation with the Covid-19 pandemic. This credit line applies for five years and is fully guaranteed by the Swiss Confederation via guaranteed organizations. The interest rate is currently at 0 percent until March 31, 2021. The Swiss Confederation has the right to adjust the interest rate to the market rate. The first revision took place as of April 1, 2021, but no modification was applied. A first amortization installment of €28 will be due on September 30, 2022. This installment is related to the period of March to September 2022. The next amortization of €14 will be due on March 31, 2023. The entire loan should be fully amortized by September 30, 2027.

Certain of the secured convertible notes have conversion features that should be bifurcated from the debt and recorded at fair value; however, as of June 30, 2022, and December 31, 2021, the probability of the conversion features being exercised was zero. For this reason, the conversion features are not required to be bifurcated from the debt as the fair value is zero at June 30, 2022, and December 31, 2021.

Note 3. Commitments

The facility lease agreement for Epalinges, Switzerland, is automatically renewed month by month with a notice period of three months. The related rent is paid monthly in the amount of €4 and is considered a short-term lease. As the term is less than twelve months, the lease is outside of the scope of ASC 842 and not accounted for on the balance sheet due to the Company’s policy elections.

The facility lease agreement for Leiden, The Netherlands, runs until March 31, 2024, and can be terminated with a six month notice as of September 30, 2023. The related rent is paid monthly in the amount of €9. The Company does not have any other operating lease for its research and development facilities, corporate headquarter, offices and equipment.

Note 4. Subsequent Events

None

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

GENERAL

The following discussion and analysis of the results of operations and financial condition of Mymetics Corporation for the periods ended June 30, 2022 and 2021 should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2021 and related notes and the description of the Company’s business and properties included elsewhere herein.

This report contains forward-looking statements that involve risks and uncertainties. The statements contained in this report are not purely historical but are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These forward-looking statements concern matters that involve risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. Words such as “may,” “will,” “should,” “could,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue”, “probably” or similar words are intended to identify forward looking statements, although not all forward-looking statements contain these words.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. We are under no duty to update any of the forward-looking statements after the date hereof to conform such statements to actual results or to changes in our expectations.

Readers are urged to carefully review and consider the various disclosures made by us which attempt to advise interested parties of the factors which affect our business, including without limitation disclosures made under the captions “Management Discussion and Analysis of Financial Condition and Results of Operations,” “Risk Factors,” “Consolidated Financial Statements” and “Notes to Consolidated Financial Statements” included in our annual report on Form 10-K for the year ended December 31, 2021 and, to the extent included therein, our quarterly reports on Form 10-Q filed during fiscal year 2022.

IMPACT OF THE NOVEL CORONAVIRUS

Management has taken measures in-line with the country requirements where we are operational and actively monitoring the impact of this global situation on its financial condition, liquidity, operations, scientific collaborations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2022.

CORONAVIRUS AID, RELIEF AND ECONOMIC SECURITY ACT

On March 27, 2020, the U.S. Government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into law. The CARES Act includes various income and payroll tax provisions. The Company has analyzed the tax provisions of the CARES Act and determined they have no significant financial impact to the condensed financial statements. The Company has no intention of taking advantage of other benefits but will continue to evaluate the impact on the Company’s financial position.

THREE MONTHS ENDED JUNE 30, 2022 AND 2021

For the three months ended June 30, 2022 and 2021, revenue was €297 and €159, respectively, which was related to the revenue recognized for the work performed under the NIH grant / HIV project.

Costs and expenses increased to €727 for the three months ended June 30, 2022 from €585 (24.3%) for the three months ended June 30, 2021, of which:

	o	Research and development expenses increased to €400 in the current period from €308 (29.9%) in the comparative period of 2021, mainly due to subcontracting services in relation with the NIH grant / HIV project incurred during the three-month period ending June 2022.

	o	General and administrative expenses increased to €327 in the three months ended June 30, 2022 from €277 (18.1%) in the comparative period of 2021, mainly due €27 incurred during the three months ended June 30, 2022 related to the engagement as of May 2022 of consultants that will seek business development opportunities for the Company with the goal of obtaining deals for licensing, financing, and/or acquisition.

Interest expense increased to €699 for the three months ended June 30, 2022 from €684 for the three months ended June 30, 2021 related to an increase in existing loans from related parties.

Foreign exchange revaluation, recorded in Other (income) expense, generated a net loss of (€196) and net gain of €33 during the three months ended June 30, 2022 and 2021, respectively, which was due to the revaluation of existing US$ based loans from related parties and US$ cash position reflecting the strong US$ with respect to the Euro.

The Company reported a net loss of (€1,342), or (€0.00) per share, for the three months ended June 30, 2022, compared to a net loss of (€1,102), or (€0.00) per share, for the three months ended June 30, 2021.

SIX MONTHS ENDED JUNE 30, 2022 AND 2021

For the six months ended June 30, 2022 and 2021, revenue was €782 and €293, respectively, which was mainly related to the revenue recognized for the work performed under the NIH grant / HIV project.

Costs and expenses increased to €1,641 for the six months ended June 30, 2022 from €1,130 (45.2%) for the six months ended June 30, 2021, of which:

	o	Research and development expenses increased to €982 in the current period from €562 (74.7%) in the comparative period of 2021, mainly due to the purchase of “influenza inactivated virus” during the first quarter in 2022 in relation with the NIH grant / HIV project.

	o	General and administrative expenses increased to €659 in the six months ended June 30, 2022 from €568 (16.0%) in the comparative period of 2021, mainly due related to the engagement as of May 2022 of consultants that will seek business development opportunities for the Company with the goal of obtaining deals for licensing, financing, and/or acquisition.

Foreign exchange revaluation, recorded in Other (income) expense, generated a net loss of €266 and €79 during the six months ended June 30, 2022 and 2021, respectively, which is due to the revaluation of existing US$ based loans from related parties and US$ cash position, reflecting the strong US$ in relation to the Euro.

The Company reported a net loss of (€2,553), or (€0.01) per share, for the six months ended June 30, 2022, compared to a net loss of (€2,348), or (€0.01) per share, for the six months ended June 30, 2021.

LIQUIDITY AND CAPITAL RESOURCES

We had cash of €350 at June 30, 2022 compared to €571 at December 31, 2021.

During 2021, our revenue has mainly been generated through the NIH grant / HIV project. For 2022, new significant revenues are not expected unless and until a major licensing agreement or other commercial arrangement is entered into with respect to our technology or new grant financings are awarded.

As of June 30, 2022, we had an accumulated deficit of approximately €100 million, and had net loss of €2,553 in the six-month period ending on that date. We expect to continue to incur net losses in the future for research, development and activities related to the future licensing of our technologies, and because of the accrual of interest payable on existing loans.

Net cash used from operating activities increased to €824 for the six-month period ended June 30, 2022, compared to €797 for the same period in 2021, mainly due to the receivable related to the NIH grant / HIV project incurred during the six-month period ending June 30, 2022.

Net cash used in investing activities was €2 during the six-months ended June 30, 2022 and €10 during the same period in 2021, mainly due to new IT equipment in Epalinges in 2022 and new laboratory equipment in Leiden in 2021.

Financing activities provided net cash of 600 for the six-months ended June 30, 2022, related to new promissory notes from our main investors, and €(1) for the six-months ended June 30, 2021.

Salaries and related payroll costs represent gross salaries for two executives, our CSO of Mymetics BV and seven employees. Under Executive Employment Agreements with our CEO and two CSOs, we pay our executive officers a combined amount of €65 per month.

Our Swiss subsidiary, Mymetics S.A., has, besides the CEO and CSO, two additional employees on its payroll: Director of Finance and Head of Manufacturing and Quality. Mymetics BV has, besides the full time Chief Scientific Officer, two full-time technicians and one part-time assistant.

We intend to continue to incur additional expenditures during the next nine months for additional research and development of our HIV, Covid-19 vaccines and immunotherapy projects, which we will try to seek through collaborations with pharmaceutical companies or with not-for-profit organizations. These expenditures will relate to the continued research and testing of these prototype vaccines and are included in the monthly cash outflow described above.

In the past, we have financed our research and development activities primarily through debt and equity financings from various parties and through license and collaboration agreements and grant agreements.

We anticipate that our normal operations will require approximately €400 additional funding as of December 31, 2022. We will seek to raise the additional capital from equity or debt financings, and grants through donors and potential partnerships with major international pharmaceutical and biotechnology firms. However, there can be no assurance that it will be able to raise additional capital on satisfactory terms, or at all, to finance its operations on the longer term. In the event that we are not able to obtain such additional capital, we will be required to further restrict or even cease our operations.

Monthly fixed and recurring expenses for “Property leases” of €13 represent the monthly lease and maintenance payments to unaffiliated third parties for our offices, of which €4 is related to our executive office located at Route de la Corniche 4, 1066 Epalinges in Switzerland (100 square meters), and €9 related to Bestewil Holding B.V. and its subsidiary Mymetics B.V operating from a similar biotechnology campus near Leiden in the Netherlands, where they occupy 204 square meters.

Included in professional fees are legal fees paid to outside corporate counsel and audit and review fees paid to our independent accountants, and fees paid for investor relations.

Cumulative interest expense of €32,787 has been accrued on all of the Company’s outstanding notes and advances (see detailed table in Note 2 to the financial statements).

RECENT FINANCING ACTIVITIES

During the six-month period ending June 30, 2022, our principal source of funds has been promissory notes received in a prior quarter from our two main investors and the revenue generated through the NIH grant / HIV project.

We have filed or are in the process of filing several new grant applications with U.S. and European institutions in relation to our virosome based vaccines.

We anticipate using our current funds and those we receive in the future both to meet our working capital needs and for funding the ongoing vaccines pre-clinical research costs for new virosome vaccine.

Management anticipates that our existing capital resources will be sufficient to fund our cash requirements through the next five months. We have cash presently on hand in conjunction with the collection of receivables, based upon our current levels of expenditures and anticipated needs during this period. For 2022, we will need additional funding through future collaborative arrangements, licensing arrangements, and debt and equity financings under Regulation D and Regulation S under the Securities Act of 1933. We do not know whether additional financing will be available on commercially acceptable terms when needed. These conditions raise substantial doubt about our ability to continue as a going concern.

If management cannot raise funds on acceptable terms when needed, we may not be able to successfully commercialize our technologies, take advantage of future opportunities, or respond to unanticipated requirements. If unable to secure such additional financing when needed, we will have to curtail or suspend all or a portion of our business activities and could be required to cease operations entirely. Further, if new equity securities are issued, our shareholders may experience severe dilution of their ownership percentage.

The extent and timing of our future capital requirements will depend primarily upon the rate of our progress in the research and development of our technologies, our ability to enter into a partnership agreement with a major pharmaceutical company, and the results of our present projects and future clinical trials.

OFF-BALANCE SHEET ARRANGEMENTS

None

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

INTEREST RATE RISK

Fluctuations in interest rates may affect the fair value of financial instruments. An increase in market interest rates may increase interest payments and a decrease in market interest rates may decrease interest payments of such financial instruments. We have no debt obligations which are sensitive to interest rate fluctuations as all our notes payable have fixed interest rates, as specified on the individual loan notes.

ITEM 4. CONTROLS AND PROCEDURES

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

Under the supervision and with the participation of the Company’s management, including its Chief Executive Officer and Chief Financial Officer the Company conducted an evaluation of the effectiveness of the Company’s disclosure controls and procedures, as defined in Rule 13a−15(e) and 15d15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this report. Based on this evaluation, the Company’s Chief Executive Officer and Chief Financial Officer (currently the same person to allow timely decisions regarding required disclosure) concluded as of June 30, 2022, that the Company’s disclosure controls and procedures were not effective because of the material weakness described below.

Management’s Annual Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a15(f) and 15d15(f) under the Exchange Act). Our internal control over financial reporting includes policies and procedures designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles.

Under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, our management conducted an evaluation of the effectiveness of our internal control over financial reporting as of June 30, 2022, based on the criteria established in Internal Control Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting during the quarter ended June 30, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. No changes of internal control over financial reporting were made in the six months ended June 30, 2022.

INHERENT LIMITATIONS ON EFFECTIVENESS OF CONTROLS

Our management, Ronald Kempers, who is both CEO and CFO, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the company have been detected.

These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

PART II.OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Neither we, nor our wholly owned subsidiaries, Mymetics S.A. and Bestewil Holding B.V., nor its subsidiary Mymetics B.V., are presently involved in any litigation incident to our business.

ITEM 1A. RISK FACTORS

Not Applicable

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

None.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

EXHIBIT NUMBER		DESCRIPTION

31.1		Rule 13a-14(a)/15d-14(a) Certification of Chief

31.2		Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer

32		Section 1350 Certification of Chief Executive Officer and Chief Financial Officer

101.INS		Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MYMETICS CORPORATION

Dated: August 11, 2022	By:	/s/ Ronald Kempers
		Chief Executive Officer / Chief Financial Officer
		(Principal Executive, Financial and Accounting Officer)

EX-31.1 2 mymx_ex311.htm CERTIFICATION mymx_ex311.htm

EXHIBIT 31.1

CERTIFICATIONS

CHIEF EXECUTIVE OFFICER I, Ronald Kempers, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Mymetics Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 11, 2022

By:

/s/ Ronald Kempers

Chief Executive Officer

EX-31.2 3 mymx_ex312.htm CERTIFICATION mymx_ex312.htm

EXHIBIT 31.2

CHIEF FINANCIAL OFFICER I, Ronald Kempers, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Mymetics Corporation;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 11, 2022

By:

/s/ Ronald Kempers

Chief Financial Officer

EX-32 4 mymx_ex32.htm CERTIFICATION mymx_ex32.htm

EXHIBIT 32

PURSUANT TO 18 U.S.C. 1350

Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of Mymetics Corporation, a Delaware corporation (the "Company"), does hereby certify, to such officer's knowledge, that:

The Quarterly Report on Form 10-Q for the six months ended June 30, 2022 (the "Form 10-Q") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 11, 2022

By:

/s/ Ronald Kempers

Chief Executive Officer / Chief Financial Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as a separate disclosure document.

EX-101.SCH 5 mymx-20220630.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - The Company and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - Debt Financing link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - Commitments link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - The Company and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - Debt Financing (Tables) link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - The Company and Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - Debt Financing (Details) link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - Debt Financing (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - Commitments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 mymx-20220630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Common Stock Shares Outstanding Document Quarterly Report Document Transition Report Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Interactive Data Current Entity Address Address Line 1 Entity Address Address Line 2 Entity Address Address Line 3 Entity Address City Or Town Entity Address Postal Zip Code City Area Code Local Phone Number Security 12g Title Trading Symbol Entity Address Country CONDENSED CONSOLIDATED BALANCE SHEETS ASSETS Current Assets Cash Accounts receivable Prepaid expenses Total current assets [Assets, Current] Rent deposit Property and equipment, net of accumulated depreciation of ?480 at June 30, 2022 and ?474 at December 31, 2021 Right-of-Use Asset Goodwill Total Assets [Assets] LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) Current Liabilities Accounts payable Deferred revenue Operating Lease Liability Current Non-convertible notes payable and related accrued interest to related parties Convertible notes payable and related accrued interest to related parties Total current liabilities [Liabilities, Current] Long Term Liabilities Debt-Principal Payable to the Federal Financing Bank Operating lease liability Total long-term liabilities [Liabilities, Noncurrent] Total Liabilities [Liabilities] Commitments and Contingencies (Note 3) Shareholders' Deficit Common stock, U.S. $0.01 par value; 1,200,000,000 shares authorized; issued and outstanding 303,757,622 at June 30, 2022 and at December 31, 2021 Preferred stock, U.S. $0.01 par value; 5,000,000 shares authorized; none-issued or outstanding Additional paid-in capital Accumulated deficit Accumulated other comprehensive income Total shareholders' deficit [Stockholders' Equity Attributable to Parent] Total liabilities and shareholders' deficit [Liabilities and Equity] Property and equipment, accumulated depreciation Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) Revenue Research and development Grants Other Total revenue [Revenues] Expenses Research and development [Research and Development Expense] General and administrative Total Expenses [Costs and Expenses] Operating Loss [Operating Income (Loss)] Interest expense Other (income) expense [Other Nonoperating Income (Expense)] Loss before income tax provision [Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest] Income tax provision [Income tax provision] Net Loss [Net Income (Loss) Attributable to Parent] Other comprehensive income Foreign currency translation adjustment Comprehensive loss [Comprehensive Income (Loss), Net of Tax, Attributable to Parent] Basic and dilutive earnings per share Weighted-average shares outstanding, basic and diluted CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED) Statement [Table] Statement [Line Items] Statement Equity Components Axis Common Stock APIC Accumulated Deficit Accumulated Other Comprehensive Income Balance, shares [Shares, Issued] Balance, amount Net loss Translation adjustment Balance, shares Balance, amount CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Cash Flow from Operating Activities Net loss [Net Income (Loss), Including Portion Attributable to Noncontrolling Interest] Adjustments to reconcile net loss to net cash used in operating activities Depreciation Changes in operating assets and liabilities Receivables [Increase (Decrease) in Receivables] Accrued interest on convertible notes payable Accrued interest on non-convertible notes payable Accounts payable [Increase (Decrease) in Accounts Payable] Deferred grant Other [Increase (Decrease) in Prepaid Expenses, Other] Net cash used in operating activities [Net Cash Provided by (Used in) Operating Activities] Cash Flows from Investing Activities Purchase of property and equipment [Payments to Acquire Property, Plant, and Equipment] Net cash used in investing activities [Net Cash Provided by (Used in) Investing Activities] Cash Flows from Financing Activities Proceeds from borrowing on-line of credit with federal bank Proceeds from issuance of non-convertible notes Net cash provided by financing activities [Net Cash Provided by (Used in) Financing Activities] Effect on foreign exchange rate on cash Net change in cash [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect] Cash, beginning of period [Cash] Cash, end of period Supplemental Disclosure of Cash Flow Information: Cash paid for taxes [Income Taxes Paid] The Company and Summary of Significant Accounting Policies Note 1. The Company and Summary of Significant Accounting Policies Debt Financing Note 2. Debt Financing Commitments Note 3. Commitments Note 4. Subsequent Events BASIS OF PRESENTATION AND GOING CONCERN LEASES IMPACT OF THE NOVEL CORONAVIRUS CORONAVIRUS AID, RELIEF AND ECONOMIC SECURITY ACT PRINCIPLES OF CONSOLIDATION NEW ACCOUNTING PRONOUNCEMENT FOREIGN CURRENCY TRANSLATION CASH REVENUE RECOGNITION NIH RECEIVABLES PROPERTY AND EQUIPMENT IMPAIRMENT OF LONG LIVED ASSETS GOODWILL RESEARCH AND DEVELOPMENT WITHHOLDING TAXES TAXES ON INCOME EARNINGS PER SHARE PREFERRED STOCK ESTIMATES FAIR VALUE MEASUREMENTS FAIR VALUES OF FINANCIAL INSTRUMENTS CONCENTRATIONS RELATED PARTY TRANSACTIONS Convertible notes, loans and contingent liabilities Debt Instrument [Axis] Plan Name [Axis] Concentration Risk Type [Axis] Note 1 [Member] Stock Option [Member] First Year [Member] Second Year [Member] Third Year [Member] Grant Revenue [Member] Accumulated deficit Current liabilities exceeding current assets Preferred stock shares authorized Potentially shares issuable EX-101.CAL 7 mymx-20220630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 8 mymx-20220630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 9 mymx-20220630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 10 R1.htm IDEA: XBRL DOCUMENT

Cover - shares	6 Months Ended
Cover - shares	Jun. 30, 2022	Aug. 11, 2022
Cover [Abstract]
Entity Registrant Name	MYMETICS CORPORATION
Entity Central Index Key	0000927761
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Jun. 30, 2022
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Entity Common Stock Shares Outstanding		303,757,622
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-25132
Entity Incorporation State Country Code	DE
Entity Tax Identification Number	25-1741849
Entity Interactive Data Current	Yes
Entity Address Address Line 1	c/o Ernie Stern
Entity Address Address Line 2	1101 Pennsylvania Avenue, N.W
Entity Address Address Line 3	Suite 300
Entity Address City Or Town	Washington D.C.
Entity Address Postal Zip Code	20004
City Area Code	011
Local Phone Number	41 21 653 4535
Security 12g Title	Common Stock, Par Value $0.01 per share
Trading Symbol	MYMX
Entity Address Country	US

XML 11 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS - EUR (€) € in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current Assets
Cash	€ 350	€ 571
Accounts receivable	54	15
Prepaid expenses	44	87
Total current assets	448	673
Rent deposit	10	10
Property and equipment, net of accumulated depreciation of ?480 at June 30, 2022 and ?474 at December 31, 2021	33	39
Right-of-Use Asset	186	239
Goodwill	6,671	6,671
Total Assets	7,348	7,632
Current Liabilities
Accounts payable	78	47
Deferred revenue	15	0
Operating Lease Liability Current	106	110
Non-convertible notes payable and related accrued interest to related parties	9,495	8,790
Convertible notes payable and related accrued interest to related parties	60,036	58,479
Total current liabilities	69,730	67,426
Long Term Liabilities
Debt-Principal Payable to the Federal Financing Bank	169	162
Operating lease liability	83	130
Total long-term liabilities	252	292
Total Liabilities	69,982	67,718
Commitments and Contingencies (Note 3)	0	0
Shareholders' Deficit
Common stock, U.S. $0.01 par value; 1,200,000,000 shares authorized; issued and outstanding 303,757,622 at June 30, 2022 and at December 31, 2021	2,530	2,530
Preferred stock, U.S. $0.01 par value; 5,000,000 shares authorized; none-issued or outstanding	0	0
Additional paid-in capital	34,443	34,443
Accumulated deficit	(100,303)	(97,750)
Accumulated other comprehensive income	696	691
Total shareholders' deficit	(62,634)	(60,086)
Total liabilities and shareholders' deficit	€ 7,348	€ 7,632

XML 12 R3.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Parenthetical) - EUR (€) € in Thousands	Jun. 30, 2022	Dec. 31, 2021
CONDENSED CONSOLIDATED BALANCE SHEETS
Property and equipment, accumulated depreciation	€ 480	€ 474
Common stock, par value	€ 0.01	€ 0.01
Common stock, shares authorized	1,200,000,000	1,200,000,000
Common stock, shares issued	303,757,622	303,757,622
Common stock, shares outstanding	303,757,622	303,757,622
Preferred stock, par value	€ 0.01	€ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

XML 13 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) - EUR (€) € in Thousands, shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenue
Research and development	€ 0	€ 0	€ 0	€ 3
Grants	297	159	779	290
Other	0	0	3	0
Total revenue	297	159	782	293
Expenses
Research and development	400	308	982	562
General and administrative	327	277	659	568
Total Expenses	727	585	1,641	1,130
Operating Loss	(430)	(426)	(859)	(837)
Interest expense	699	684	1,393	1,369
Other (income) expense	213	(22)	301	100
Loss before income tax provision	(1,342)	(1,088)	(2,553)	(2,306)
Income tax provision	0	(14)	0	(42)
Net Loss	(1,342)	(1,102)	(2,553)	(2,348)
Other comprehensive income
Foreign currency translation adjustment	(2)	1	5	(7)
Comprehensive loss	€ (1,344)	€ (1,101)	€ (2,548)	€ (2,355)
Basic and dilutive earnings per share	€ (0.00)	€ (0.00)	€ (0.01)	€ (0.01)
Weighted-average shares outstanding, basic and diluted	303,757,622	303,757,622	303,757,622	303,757,622

XML 14 R5.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED) - EUR (€) € in Thousands, shares in Thousands	Total	Common Stock	APIC	Accumulated Deficit	Accumulated Other Comprehensive Income
Balance, shares at Dec. 31, 2020		303,757,622
Balance, amount at Dec. 31, 2020	€ (55,352)	€ 2,530	€ 34,443	€ (93,020)	€ 695
Net loss	(1,246)	0	0	(1,246)	0
Translation adjustment	(8)	€ 0	0	0	(8)
Balance, shares at Mar. 31, 2021		303,757,622
Balance, amount at Mar. 31, 2021	(56,606)	€ 2,530	34,443	(94,266)	687
Balance, shares at Dec. 31, 2020		303,757,622
Balance, amount at Dec. 31, 2020	(55,352)	€ 2,530	34,443	(93,020)	695
Net loss	(2,348)
Balance, shares at Jun. 30, 2021		303,757,622
Balance, amount at Jun. 30, 2021	(57,707)	€ 2,530	34,443	(95,368)	688
Balance, shares at Mar. 31, 2021		303,757,622
Balance, amount at Mar. 31, 2021	(56,606)	€ 2,530	34,443	(94,266)	687
Net loss	(1,102)	0	0	(1,102)	0
Translation adjustment	1	€ 0	0	0	1
Balance, shares at Jun. 30, 2021		303,757,622
Balance, amount at Jun. 30, 2021	(57,707)	€ 2,530	34,443	(95,368)	688
Balance, shares at Dec. 31, 2021		303,757,622
Balance, amount at Dec. 31, 2021	(60,086)	€ 2,530	34,443	(97,750)	691
Net loss	(1,211)	0	0	(1,211)	0
Translation adjustment	7	€ 0	0	0	7
Balance, shares at Mar. 31, 2022		303,757,622
Balance, amount at Mar. 31, 2022	(61,290)	€ 2,530	34,443	(98,961)	698
Balance, shares at Dec. 31, 2021		303,757,622
Balance, amount at Dec. 31, 2021	(60,086)	€ 2,530	34,443	(97,750)	691
Net loss	(2,553)
Balance, shares at Jun. 30, 2022		303,757,622
Balance, amount at Jun. 30, 2022	(62,634)	€ 2,530	34,443	(100,303)	696
Balance, shares at Mar. 31, 2022		303,757,622
Balance, amount at Mar. 31, 2022	(61,290)	€ 2,530	34,443	(98,961)	698
Net loss	(1,342)	0	0	(1,342)	0
Translation adjustment	(2)	€ 0	0	0	(2)
Balance, shares at Jun. 30, 2022		303,757,622
Balance, amount at Jun. 30, 2022	€ (62,634)	€ 2,530	€ 34,443	€ (100,303)	€ 696

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

XML 15 R6.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - EUR (€) € in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash Flow from Operating Activities
Net loss	€ (2,553)	€ (2,348)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	8	9
Changes in operating assets and liabilities
Receivables	(39)	15
Accrued interest on convertible notes payable	1,557	1,370
Accrued interest on non-convertible notes payable	105	88
Accounts payable	31	(14)
Deferred grant	15	36
Other	52	46
Net cash used in operating activities	(824)	(798)
Cash Flows from Investing Activities
Purchase of property and equipment	(2)	(10)
Net cash used in investing activities	(2)	(10)
Cash Flows from Financing Activities
Proceeds from borrowing on-line of credit with federal bank	0	0
Proceeds from issuance of non-convertible notes	600	0
Net cash provided by financing activities	600	0
Effect on foreign exchange rate on cash	5	(7)
Net change in cash	(221)	(815)
Cash, beginning of period	571	1,083
Cash, end of period	350	268
Supplemental Disclosure of Cash Flow Information:
Cash paid for taxes	€ 0	€ (38)

XML 16 R7.htm IDEA: XBRL DOCUMENT

The Company and Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2022

The Company and Summary of Significant Accounting Policies

Note 1. The Company and Summary of Significant Accounting Policies

BASIS OF PRESENTATION AND GOING CONCERN

The amounts in the notes are shown in thousands of EURO, unless otherwise noted, and rounded to the nearest thousand except for share and per share amounts.

LEASES

IMPACT OF THE NOVEL CORONAVIRUS

CORONAVIRUS AID, RELIEF AND ECONOMIC SECURITY ACT

PRINCIPLES OF CONSOLIDATION

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. Significant intercompany accounts and transactions have been eliminated.

NEW ACCOUNTING PRONOUNCEMENT

FOREIGN CURRENCY TRANSLATION

CASH

The Company consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents. Cash deposits are occasionally in excess of insured amounts.

REVENUE RECOGNITION

NIH

Option to License Agreement – ANERGIS SA

RECEIVABLES

PROPERTY AND EQUIPMENT

IMPAIRMENT OF LONG-LIVED ASSETS

GOODWILL

RESEARCH AND DEVELOPMENT

Research and development costs are expensed as incurred.

WITHHOLDING TAXES

TAXES ON INCOME

EARNINGS PER SHARE

PREFERRED STOCK

ESTIMATES

FAIR VALUE MEASUREMENTS

Fair value guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include:

Level 1-

Quoted prices in active markets for identical assets or liabilities.

Level 2-

Level 3-

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the

assets or liabilities.

FAIR VALUES OF FINANCIAL INSTRUMENTS

CONCENTRATIONS

RELATED PARTY TRANSACTIONS

XML 17 R8.htm IDEA: XBRL DOCUMENT

Debt Financing

6 Months Ended

Jun. 30, 2022

Debt Financing

Note 2. Debt Financing

The details of the convertible notes and loans are as follows at June 30, 2022:

									Fixed
								Conversion	Rate
Lender	1st-Issue	Principal		Duration		Interest		Price	EUR/USD
Price	Date	Amount		(Note)		Rate		(stated)	Conversion

Eardley Holding A.G. (1)	06/23/2006	€	182	(2	)	10% pa	$	0.10	N/A
Anglo Irish Bank S.A.(3)	10/21/2007	€	500	(2	)	10% pa	$	0.50	1.4090
Round Enterprises Ltd.	12/10/2007	€	1,500	(2	)	10% pa	$	0.50	1.4429
Round Enterprises Ltd.	01/22/2008	€	1,500	(2	)	10% pa	$	0.50	1.4629
Round Enterprises Ltd.	04/25/2008	€	2,000	(2	)	10% pa	$	0.50	1.5889
Round Enterprises Ltd.	06/30/2008	€	1,500	(2	)	10% pa	$	0.50	1.5380
Round Enterprises Ltd.	11/18/2008	€	1,200	(2	)	10% pa	$	0.50	1.2650
Round Enterprises Ltd.	02/09/2009	€	1,500	(2	)	10% pa	$	0.50	1.2940
Round Enterprises Ltd.	06/15/2009	€	5,500	(2,4	)	10% pa	$	0.80	1.4045
Eardley Holding A.G.	06/15/2009	€	100	(2,4	)	10% pa	$	0.80	1.4300
Von Meyenburg	08/03/2009	€	200	(2	)	10% pa	$	0.80	1.4400
Round Enterprises Ltd.	10/13/2009	€	2,000	(2	)	5% pa	$	0.25	1.4854
Round Enterprises Ltd.	12/18/2009	€	2,200	(2	)	5% pa	$	0.25	1.4338
Round Enterprises Ltd.	08/04/2011	€	1,148	(5,6	)	10% pa	$	0.034	N/A
Eardley Holding A.G.	08/04/2011	€	297	(5,6	)	10% pa	$	0.034	N/A
Round Enterprises Ltd.	11/08/2011	€	400	(6	)	10% pa	$	0.034	1.3787
Eardley Holding A.G.	11/08/2011	€	100	(6	)	10% pa	$	0.034	1.3787
Round Enterprises Ltd.	02/10/2012	€	1,000	(6	)	10% pa	$	0.034	1.3260
Eardley Holding A.G.	02/14/2012	€	200	(6	)	10% pa	$	0.034	1.3260
Round Enterprises Ltd.	04/19/2012	€	322	(6	)	10% pa	$	0.034	1.3100
Eardley Holding A.G.	04/19/2012	€	80	(6	)	10% pa	$	0.034	1.3100
Round Enterprises Ltd.	05/04/2012	€	480	(6	)	10% pa	$	0.034	1.3152
Eardley Holding A.G.	05/04/2012	€	120	(6	)	10% pa	$	0.034	1.3152
Round Enterprises Ltd.	09/03/2012	€	200	(6	)	10% pa	$	0.034	1.2576
Eardley Holding A.G.	09/03/2012	€	50	(6	)	10% pa	$	0.034	1.2576
Round Enterprises Ltd.	11/14/2012	€	500	(6	)	10% pa	$	0.034	1.2718
Eardley Holding A.G.	12/06/2012	€	125	(6	)	10% pa	$	0.034	1.3070
Round Enterprises Ltd.	01/16/2013	€	240	(6	)	10% pa	$	0.034	1.3318
Eardley Holding A.G.	01/16/2013	€	60	(6	)	10% pa	$	0.034	1.3318
Round Enterprises Ltd.	03/25/2013	€	400	(6	)	10% pa	$	0.037	1.2915
Eardley Holding A.G.	04/14/2013	€	150	(6	)	10% pa	$	0.034	1.3056
Round Enterprises Ltd.	04/14/2013	€	600	(6	)	10% pa	$	0.034	1.3056
Eardley Holding A.G.	05/15/2013	€	170	(6	)	10% pa	$	0.037	1.2938
Round Enterprises Ltd.	05/15/2013	€	680	(6	)	10% pa	$	0.037	1.2938
Eardley Holding A.G.	06/24/2013	€	60	(6	)	10% pa	$	0.025	1.3340
Round Enterprises Ltd.	06/24/2013	€	240	(6	)	10% pa	$	0.025	1.3340
Eardley Holding A.G.	08/05/2013	€	80	(6	)	10% pa	$	0.018	1.3283
Round Enterprises Ltd.	08/05/2013	€	320	(6	)	10% pa	$	0.018	1.3283
Eardley Holding A.G.	03/01/2017	€	230	(7	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	03/01/2017	€	920	(7	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	10/18/2017	€	230	(7	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	10/18/2017	€	920	(7	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	06/01/2018	€	160	(8	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	06/01/2018	€	640	(8	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	11/10/2018	€	160	(8	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	11/10/2018	€	640	(8	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	06/15/2019	€	120	(9	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	06/15/2019	€	480	(9	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	12/20/2019	€	120	(10	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	12/20/2019	€	480	(10	)	2.5% pa		N/A	N/A
Eardley Holding AG	06/15/2020	€	220	(11	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	06/15/2020	€	880	(11	)	2.5% pa		N/A	N/A
Eardley Holding AG	12/15/2020	€	170	(12	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	12/15/2020	€	680	(12	)	2.5% pa		N/A	N/A
Eardley Holding AG	08/15/2021	€	240	(13	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	08/15/2021	€	960	(13	)	2.5% pa		N/A	N/A
Eardley Holding AG	04/30/2022	€	120	(14	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	04/30/2022	€	480	(14	)	2.5% pa		N/A	N/A
Total Short Term Principal Amounts		€	36,744
Accrued Interest		€	32,787
TOTAL LOANS AND NOTES		€	69,531

(1) Private investment company of Dr. Thomas Staehelin, member of the Board of Directors and of the Audit Committee of the Company. Face value is stated in U.S. dollars at $190.

(2) This maturity date is automatically prolonged for periods of three months, unless called for repayment.

(3) Renamed Hyposwiss Private Bank Genève S.A. and acting on behalf of Round Enterprises Ltd. which is a major shareholder.

(4) The loan is secured against 2/3rds of the IP assets of Bestewil Holding BV and against all property of the Company.

(5) The face values of the loans are stated in U.S. dollars at $1,200 and $300, respectively.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI https://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

XML 18 R9.htm IDEA: XBRL DOCUMENT

Commitments

6 Months Ended

Jun. 30, 2022

Commitments

Note 3. Commitments

XML 19 R10.htm IDEA: XBRL DOCUMENT

Subsequent Events

6 Months Ended

Jun. 30, 2022

Commitments

Note 4. Subsequent Events

None

XML 20 R11.htm IDEA: XBRL DOCUMENT

The Company and Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2022

The Company and Summary of Significant Accounting Policies

BASIS OF PRESENTATION AND GOING CONCERN

The amounts in the notes are shown in thousands of EURO, unless otherwise noted, and rounded to the nearest thousand except for share and per share amounts.

LEASES

IMPACT OF THE NOVEL CORONAVIRUS

CORONAVIRUS AID, RELIEF AND ECONOMIC SECURITY ACT

PRINCIPLES OF CONSOLIDATION

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. Significant intercompany accounts and transactions have been eliminated.

NEW ACCOUNTING PRONOUNCEMENT

FOREIGN CURRENCY TRANSLATION

CASH

The Company consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents. Cash deposits are occasionally in excess of insured amounts.

REVENUE RECOGNITION

NIH

Option to License Agreement – ANERGIS SA

RECEIVABLES

PROPERTY AND EQUIPMENT

IMPAIRMENT OF LONG LIVED ASSETS

GOODWILL

RESEARCH AND DEVELOPMENT

Research and development costs are expensed as incurred.

FAIR VALUE MEASUREMENTS

Fair value guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include:

Level 1-

Quoted prices in active markets for identical assets or liabilities.

Level 2-

Level 3-

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the

assets or liabilities.

FAIR VALUES OF FINANCIAL INSTRUMENTS

CONCENTRATIONS

RELATED PARTY TRANSACTIONS

XML 21 R12.htm IDEA: XBRL DOCUMENT

Debt Financing (Tables)

6 Months Ended

Jun. 30, 2022

Debt Financing

Convertible notes, loans and contingent liabilities

									Fixed
								Conversion	Rate
Lender	1st-Issue	Principal		Duration		Interest		Price	EUR/USD
Price	Date	Amount		(Note)		Rate		(stated)	Conversion

Eardley Holding A.G. (1)	06/23/2006	€	182	(2	)	10% pa	$	0.10	N/A
Anglo Irish Bank S.A.(3)	10/21/2007	€	500	(2	)	10% pa	$	0.50	1.4090
Round Enterprises Ltd.	12/10/2007	€	1,500	(2	)	10% pa	$	0.50	1.4429
Round Enterprises Ltd.	01/22/2008	€	1,500	(2	)	10% pa	$	0.50	1.4629
Round Enterprises Ltd.	04/25/2008	€	2,000	(2	)	10% pa	$	0.50	1.5889
Round Enterprises Ltd.	06/30/2008	€	1,500	(2	)	10% pa	$	0.50	1.5380
Round Enterprises Ltd.	11/18/2008	€	1,200	(2	)	10% pa	$	0.50	1.2650
Round Enterprises Ltd.	02/09/2009	€	1,500	(2	)	10% pa	$	0.50	1.2940
Round Enterprises Ltd.	06/15/2009	€	5,500	(2,4	)	10% pa	$	0.80	1.4045
Eardley Holding A.G.	06/15/2009	€	100	(2,4	)	10% pa	$	0.80	1.4300
Von Meyenburg	08/03/2009	€	200	(2	)	10% pa	$	0.80	1.4400
Round Enterprises Ltd.	10/13/2009	€	2,000	(2	)	5% pa	$	0.25	1.4854
Round Enterprises Ltd.	12/18/2009	€	2,200	(2	)	5% pa	$	0.25	1.4338
Round Enterprises Ltd.	08/04/2011	€	1,148	(5,6	)	10% pa	$	0.034	N/A
Eardley Holding A.G.	08/04/2011	€	297	(5,6	)	10% pa	$	0.034	N/A
Round Enterprises Ltd.	11/08/2011	€	400	(6	)	10% pa	$	0.034	1.3787
Eardley Holding A.G.	11/08/2011	€	100	(6	)	10% pa	$	0.034	1.3787
Round Enterprises Ltd.	02/10/2012	€	1,000	(6	)	10% pa	$	0.034	1.3260
Eardley Holding A.G.	02/14/2012	€	200	(6	)	10% pa	$	0.034	1.3260
Round Enterprises Ltd.	04/19/2012	€	322	(6	)	10% pa	$	0.034	1.3100
Eardley Holding A.G.	04/19/2012	€	80	(6	)	10% pa	$	0.034	1.3100
Round Enterprises Ltd.	05/04/2012	€	480	(6	)	10% pa	$	0.034	1.3152
Eardley Holding A.G.	05/04/2012	€	120	(6	)	10% pa	$	0.034	1.3152
Round Enterprises Ltd.	09/03/2012	€	200	(6	)	10% pa	$	0.034	1.2576
Eardley Holding A.G.	09/03/2012	€	50	(6	)	10% pa	$	0.034	1.2576
Round Enterprises Ltd.	11/14/2012	€	500	(6	)	10% pa	$	0.034	1.2718
Eardley Holding A.G.	12/06/2012	€	125	(6	)	10% pa	$	0.034	1.3070
Round Enterprises Ltd.	01/16/2013	€	240	(6	)	10% pa	$	0.034	1.3318
Eardley Holding A.G.	01/16/2013	€	60	(6	)	10% pa	$	0.034	1.3318
Round Enterprises Ltd.	03/25/2013	€	400	(6	)	10% pa	$	0.037	1.2915
Eardley Holding A.G.	04/14/2013	€	150	(6	)	10% pa	$	0.034	1.3056
Round Enterprises Ltd.	04/14/2013	€	600	(6	)	10% pa	$	0.034	1.3056
Eardley Holding A.G.	05/15/2013	€	170	(6	)	10% pa	$	0.037	1.2938
Round Enterprises Ltd.	05/15/2013	€	680	(6	)	10% pa	$	0.037	1.2938
Eardley Holding A.G.	06/24/2013	€	60	(6	)	10% pa	$	0.025	1.3340
Round Enterprises Ltd.	06/24/2013	€	240	(6	)	10% pa	$	0.025	1.3340
Eardley Holding A.G.	08/05/2013	€	80	(6	)	10% pa	$	0.018	1.3283
Round Enterprises Ltd.	08/05/2013	€	320	(6	)	10% pa	$	0.018	1.3283
Eardley Holding A.G.	03/01/2017	€	230	(7	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	03/01/2017	€	920	(7	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	10/18/2017	€	230	(7	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	10/18/2017	€	920	(7	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	06/01/2018	€	160	(8	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	06/01/2018	€	640	(8	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	11/10/2018	€	160	(8	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	11/10/2018	€	640	(8	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	06/15/2019	€	120	(9	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	06/15/2019	€	480	(9	)	2.5% pa		N/A	N/A
Eardley Holding A.G.	12/20/2019	€	120	(10	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	12/20/2019	€	480	(10	)	2.5% pa		N/A	N/A
Eardley Holding AG	06/15/2020	€	220	(11	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	06/15/2020	€	880	(11	)	2.5% pa		N/A	N/A
Eardley Holding AG	12/15/2020	€	170	(12	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	12/15/2020	€	680	(12	)	2.5% pa		N/A	N/A
Eardley Holding AG	08/15/2021	€	240	(13	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	08/15/2021	€	960	(13	)	2.5% pa		N/A	N/A
Eardley Holding AG	04/30/2022	€	120	(14	)	2.5% pa		N/A	N/A
Round Enterprises Ltd.	04/30/2022	€	480	(14	)	2.5% pa		N/A	N/A
Total Short Term Principal Amounts		€	36,744
Accrued Interest		€	32,787
TOTAL LOANS AND NOTES		€	69,531

XML 22 R13.htm IDEA: XBRL DOCUMENT

The Company and Summary of Significant Accounting Policies (Details Narrative) - EUR (€)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Accumulated deficit	€ (100,303,000)		€ (100,303,000)		€ (97,750,000)
Current liabilities exceeding current assets	€ 69,282		€ 69,282
Preferred stock shares authorized	5,000,000		5,000,000		5,000,000
Potentially shares issuable	758,730,472		784,480,472
Potentially shares issuable convertible loans	758,730,472		758,730,472	758,730,472
Sub award grant revenue USD			€ 842
Sub award grant revenue euro			779
Sub award project cost USD			2,666
Sub award project cost euro			€ 2,527
Basic weighted and diluted	303,757,622		303,757,622	303,757,622
Professional fees	€ 27	€ 3	€ 33	€ 14
Carrying amount			€ 69,073
Budget description			The overall budget related to the project is US$8,850 with US$1,940 approved for the first year, US$1,856 approved for the second year, and US$1,720 for the third year. In April 2022, the Company filed a report to the NIH in collaboration with ULL, to validate funds for the fifth year of the ongoing HIV project (May 2022 to April 2023). The funds for the fourth year were approved in May 2022 with a total budget of US$ 1,616.
Grant allocated description			The amounts mentioned in the following statements are purely related to the Company and not to the other partners in the project: The overall portion of the grant allocated to the Company is US$5,930, with US$1,190 approved for the first year, US$1,052 for the second year, US$ 1,078 for the third year and US$1,328 approved in June 2022 for the fourth year.
Grant Revenue [Member]
Concentration risk percentage			100.00%	99.00%
First Year [Member]
Sub award project cost USD			€ 547
Sub award project cost euro			542
Second Year [Member]
Sub award project cost USD			870
Third Year [Member]
Sub award project cost USD			€ 1,078
Note 1 [Member]
Potentially shares issuable			747,880,794	747,880,794
Potentially shares issuable convertible loans				722,130,794
Stock Option [Member]
Potentially shares issuable			25,750,000	25,750,000

XML 23 R14.htm IDEA: XBRL DOCUMENT

Debt Financing (Details) € / shares in Units, € in Thousands	6 Months Ended
	Jun. 30, 2022 EUR (€) € / shares
Total short term principal amounts	€ 36,744
Accrued interest	32,787
Total loans and notes	€ 69,531
Issuance date	04/30/2022
Interest rate	2.50%
Principal amount	€ 480
Note 1 [Member]
Issuance date	06/23/2006
Interest rate	10.00%
Principal amount	€ 182
Conversion price \| € / shares	€ 0.10
Fixed rate conversion	0
Note 2 [Member]
Issuance date	10/21/2007
Interest rate	10.00%
Principal amount	€ 500
Conversion price \| € / shares	€ 0.50
Fixed rate conversion	1.4090
Note 3 [Member]
Issuance date	12/10/2007
Interest rate	10.00%
Principal amount	€ 1,500
Conversion price \| € / shares	€ 0.50
Fixed rate conversion	1.4429
Note 4 [Member]
Issuance date	01/22/2008
Interest rate	10.00%
Principal amount	€ 1,500
Conversion price \| € / shares	€ 0.50
Fixed rate conversion	1.4629
Note 5 [Member]
Issuance date	04/25/2008
Interest rate	10.00%
Principal amount	€ 2,000
Conversion price \| € / shares	€ 0.50
Fixed rate conversion	1.5889
Note 6 [Member]
Issuance date	06/30/2008
Interest rate	10.00%
Principal amount	€ 1,500
Conversion price \| € / shares	€ 0.50
Fixed rate conversion	1.5380
Note 7 [Member]
Issuance date	11/18/2008
Interest rate	10.00%
Principal amount	€ 1,200
Conversion price \| € / shares	€ 0.50
Fixed rate conversion	1.2650
Note 8 [Member]
Issuance date	02/09/2009
Interest rate	10.00%
Principal amount	€ 1,500
Conversion price \| € / shares	€ 0.50
Fixed rate conversion	1.2940
Note 9 [Member]
Issuance date	06/15/2009
Interest rate	10.00%
Principal amount	€ 5,500
Conversion price \| € / shares	€ 0.80
Fixed rate conversion	1.4045
Note 10 [Member]
Issuance date	06/15/2009
Interest rate	10.00%
Principal amount	€ 100
Conversion price \| € / shares	€ 0.80
Fixed rate conversion	1.4300
Note 11 [Member]
Issuance date	08/03/2009
Interest rate	10.00%
Principal amount	€ 200
Conversion price \| € / shares	€ 0.80
Fixed rate conversion	1.4400
Note 12 [Member]
Issuance date	10/13/2009
Interest rate	5.00%
Principal amount	€ 2,000
Conversion price \| € / shares	€ 0.25
Fixed rate conversion	1.4854
Note 13 [Member]
Issuance date	12/18/2009
Interest rate	5.00%
Principal amount	€ 2,200
Conversion price \| € / shares	€ 0.25
Fixed rate conversion	1.4338
Note 14 [Member]
Issuance date	08/04/2011
Interest rate	10.00%
Principal amount	€ 1,148
Conversion price \| € / shares	€ 0.034
Note 15 [Member]
Issuance date	08/04/2011
Interest rate	10.00%
Principal amount	€ 297
Conversion price \| € / shares	€ 0.034
Note 16 [Member]
Issuance date	11/08/2011
Interest rate	10.00%
Principal amount	€ 400
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3787
Note 17 [Member]
Issuance date	11/08/2011
Interest rate	10.00%
Principal amount	€ 100
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3787
Note 18 [Member]
Issuance date	02/10/2012
Interest rate	10.00%
Principal amount	€ 1,000
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3260
Note 19 [Member]
Issuance date	02/14/2012
Interest rate	10.00%
Principal amount	€ 200
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3260
Note 20 [Member]
Issuance date	04/19/2012
Interest rate	10.00%
Principal amount	€ 322
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3100
Note 21 [Member]
Issuance date	04/19/2012
Interest rate	10.00%
Principal amount	€ 80
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3100
Note 22 [Member]
Issuance date	05/04/2012
Interest rate	10.00%
Principal amount	€ 480
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3152
Note 23 [Member]
Issuance date	05/04/2012
Interest rate	10.00%
Principal amount	€ 120
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3152
Note 24 [Member]
Issuance date	09/03/2012
Interest rate	10.00%
Principal amount	€ 200
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.2576
Note 25 [Member]
Issuance date	09/03/2012
Interest rate	10.00%
Principal amount	€ 50
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.2576
Note 26 [Member]
Issuance date	11/14/2012
Interest rate	10.00%
Principal amount	€ 500
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.2718
Note 27 [Member]
Issuance date	12/06/2012
Interest rate	10.00%
Principal amount	€ 125
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3070
Note 28 [Member]
Issuance date	01/16/2013
Interest rate	10.00%
Principal amount	€ 240
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3318
Note 29 [Member]
Issuance date	01/16/2013
Interest rate	10.00%
Principal amount	€ 60
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3318
Note 30 [Member]
Issuance date	03/25/2013
Interest rate	10.00%
Principal amount	€ 400
Conversion price \| € / shares	€ 0.037
Fixed rate conversion	1.2915
Note 31 [Member]
Issuance date	04/14/2013
Interest rate	10.00%
Principal amount	€ 150
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3056
Note 32 [Member]
Issuance date	04/14/2013
Interest rate	10.00%
Principal amount	€ 600
Conversion price \| € / shares	€ 0.034
Fixed rate conversion	1.3056
Note 33 [Member]
Issuance date	05/15/2013
Interest rate	10.00%
Principal amount	€ 170
Conversion price \| € / shares	€ 0.037
Fixed rate conversion	1.2938
Note 34 [Member]
Issuance date	05/15/2013
Interest rate	10.00%
Principal amount	€ 680
Conversion price \| € / shares	€ 0.037
Fixed rate conversion	1.2938
Note 35 [Member]
Issuance date	06/24/2013
Interest rate	10.00%
Principal amount	€ 60
Conversion price \| € / shares	€ 0.025
Fixed rate conversion	1.3340
Note 36 [Member]
Issuance date	06/24/2013
Interest rate	10.00%
Principal amount	€ 240
Conversion price \| € / shares	€ 0.025
Fixed rate conversion	1.3340
Note 37 [Member]
Issuance date	08/05/2013
Interest rate	10.00%
Principal amount	€ 80
Conversion price \| € / shares	€ 0.018
Fixed rate conversion	1.3283
Note 38 [Member]
Issuance date	08/05/2013
Interest rate	10.00%
Principal amount	€ 320
Conversion price \| € / shares	€ 0.018
Fixed rate conversion	1.3283
Note 39 [Member]
Issuance date	03/01/2017
Interest rate	2.50%
Principal amount	€ 230
Note 40 [Member]
Issuance date	03/01/2017
Interest rate	2.50%
Principal amount	€ 920
Note 41 [Member]
Issuance date	10/18/2017
Interest rate	2.50%
Principal amount	€ 230
Note 42 [Member]
Issuance date	10/18/2017
Interest rate	2.50%
Principal amount	€ 920
Note 43 [Member]
Issuance date	06/01/2018
Interest rate	2.50%
Principal amount	€ 160
Note 44 [Member]
Issuance date	06/01/2018
Interest rate	2.50%
Principal amount	€ 640
Note 45 [Member]
Issuance date	11/10/2018
Interest rate	2.50%
Principal amount	€ 160
Note 46 [Member]
Issuance date	11/10/2018
Interest rate	2.50%
Principal amount	€ 640
Note 47 [Member]
Issuance date	06/15/2019
Interest rate	2.50%
Principal amount	€ 120
Note 48 [Member]
Issuance date	06/15/2019
Interest rate	2.50%
Principal amount	€ 480
Note 49 [Member]
Issuance date	12/20/2019
Interest rate	2.50%
Principal amount	€ 120
Note 50 [Member]
Issuance date	12/20/2019
Interest rate	2.50%
Principal amount	€ 480
Note 51 [Member]
Issuance date	06/15/2020
Interest rate	2.50%
Principal amount	€ 220
Note 52 [Member]
Issuance date	06/15/2020
Interest rate	2.50%
Principal amount	€ 880
Note 53 [Member]
Issuance date	12/15/2020
Interest rate	2.50%
Principal amount	€ 170
Note 54 [Member]
Issuance date	12/15/2020
Interest rate	2.50%
Principal amount	€ 680
Note 55 [Member]
Issuance date	08/15/2021
Interest rate	2.50%
Principal amount	€ 240
Note 56 [Member]
Issuance date	08/15/2021
Interest rate	2.50%
Principal amount	€ 960
Note 57 [Member]
Issuance date	04/30/2022
Interest rate	2.50%
Principal amount	€ 120

XML 24 R15.htm IDEA: XBRL DOCUMENT

Debt Financing (Details Narrative) - EUR (€) € in Thousands					1 Months Ended				6 Months Ended
Debt Financing (Details Narrative) - EUR (€) € in Thousands	Aug. 15, 2021	Dec. 15, 2020	Jun. 01, 2018	Mar. 01, 2017	Apr. 30, 2022	Jun. 15, 2020	Dec. 20, 2019	Jun. 15, 2019	Jun. 30, 2022	Apr. 02, 2020
Debt Financing
Amortization installment description									A first amortization installment of €28 will be due on September 30, 2022. This installment is related to the period of March to September 2022. The next amortization of €14 will be due on March 31, 2023. The entire loan should be fully amortized by September 30, 2027.
Debt instruments description	The promissory Notes of €960 and €240, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.	The promissory Notes of €680 and €170, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) March 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.	The first tranche of the promissory Notes of €640 and €160, respectively, were provided immediately. The second tranche of the promissory notes of €640 and €160, respectively, were provided on November 10, 2018, with a 2.5% interest per annum.	The first 50% of the promissory Notes of €920 and €230, respectively, were provided immediately. The second 50% of the promissory notes of €920 and €230, respectively, were provided on October 18, 2017, with a 2.5% interest per annum and a maturity date of October 18, 2018	The first tranche of the promissory Notes of €480 and €120, respectively, were provided immediately. The second tranche of the promissory notes of €480 and €120, respectively, will be provided in August, 2022, with a 2.5% interest per annum.	The promissory Notes of €880 and €220, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.	The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.	The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.
Received from federal credit line										€ 156
Interest rate	2.50%	2.50%	2.50%	2.50%	2.50%	2.50%	2.50%	2.50%
Promissory Notes Tranches 1			€ 1,280
Promissory Notes Tranches 2			€ 320
Promissory Notes	€ 1,200	€ 850				€ 1,100	€ 600	€ 600
Debt instrument face value 1									€ 190
Promissory Notes Round Enterprises					€ 960
Promissory Notes Eardley Holding AG					€ 240
Debt instrument face value 2									1,200
Debt instrument face value 3									€ 300
Description of conversion price									reducing by 10% the price per share of the Company’s common stock paid by the investors in connection with an investment in the Company of not less than US$20,000, or (ii) at the fixed conversion price using a fixed exchange rate which are noted in the table above
Promissory Notes 1				€ 1,840
Promissory Notes 2				€ 460
Total loans and notes									€ 69,531

XML 25 R16.htm IDEA: XBRL DOCUMENT

Commitments (Details Narrative) € in Thousands	6 Months Ended
Commitments (Details Narrative) € in Thousands	Jun. 30, 2022 EUR (€)
Switzerlands [Member]
Rent paid per month	€ 4
Netherlands [Member]
Rent paid per month	€ 9

XML 26 mymx_10q_htm.xml IDEA: XBRL DOCUMENT 0000927761 2022-01-01 2022-06-30 0000927761 mymx:NetharlandsMember 2022-01-01 2022-06-30 0000927761 mymx:SwitzerlandsMember 2022-01-01 2022-06-30 0000927761 2022-04-30 0000927761 2021-08-15 0000927761 2020-12-15 0000927761 2020-06-15 0000927761 2019-12-20 0000927761 2019-06-15 0000927761 2018-06-01 0000927761 2017-03-01 0000927761 2020-04-02 0000927761 2022-04-01 2022-04-30 0000927761 2021-08-01 2021-08-15 0000927761 2020-12-01 2020-12-15 0000927761 2020-06-01 2020-06-15 0000927761 2019-12-01 2019-12-20 0000927761 2019-06-01 2019-06-15 0000927761 2018-05-26 2018-06-01 0000927761 2017-02-26 2017-03-01 0000927761 mymx:NoteFifySevenMember 2022-06-30 0000927761 mymx:NoteFifySixMember 2022-06-30 0000927761 mymx:NoteFiftyFiveMember 2022-06-30 0000927761 mymx:NoteFiftyFourMember 2022-06-30 0000927761 mymx:NoteFiftyThreeMember 2022-06-30 0000927761 mymx:NoteFiftyTwoMember 2022-06-30 0000927761 mymx:NoteFiftyOneMember 2022-06-30 0000927761 mymx:NoteFiftyMember 2022-06-30 0000927761 mymx:NoteFortyNineMember 2022-06-30 0000927761 mymx:NoteFortyEightMember 2022-06-30 0000927761 mymx:NoteFortySevenMember 2022-06-30 0000927761 mymx:NoteFortySixMember 2022-06-30 0000927761 mymx:NoteFortyFiveMember 2022-06-30 0000927761 mymx:NoteFortyFourMember 2022-06-30 0000927761 mymx:NoteFortyThreeMember 2022-06-30 0000927761 mymx:NoteFortyTwoMember 2022-06-30 0000927761 mymx:NoteFortyOneMember 2022-06-30 0000927761 mymx:NoteFortyMember 2022-06-30 0000927761 mymx:NoteThrityNineMember 2022-06-30 0000927761 mymx:NoteThrityEightMember 2022-06-30 0000927761 mymx:NoteThritySevenMember 2022-06-30 0000927761 mymx:NoteThritySixMember 2022-06-30 0000927761 mymx:NoteThrityFiveMember 2022-06-30 0000927761 mymx:NoteThrityFourMember 2022-06-30 0000927761 mymx:NoteThrityThreeMember 2022-06-30 0000927761 mymx:NoteThrityTwoMember 2022-06-30 0000927761 mymx:NoteThrityOneMember 2022-06-30 0000927761 mymx:NoteThrityMember 2022-06-30 0000927761 mymx:NoteTwentyNineMember 2022-06-30 0000927761 mymx:NoteTwentyEightMember 2022-06-30 0000927761 mymx:NoteTwentySevenMember 2022-06-30 0000927761 mymx:NoteTwentySixMember 2022-06-30 0000927761 mymx:NoteTwentyFiveMember 2022-06-30 0000927761 mymx:NoteTwentyFourMember 2022-06-30 0000927761 mymx:NoteTwentyThreeMember 2022-06-30 0000927761 mymx:NoteTwentyTwoMember 2022-06-30 0000927761 mymx:NoteTwentyOneMember 2022-06-30 0000927761 mymx:NoteTwentyMember 2022-06-30 0000927761 mymx:NoteNinteenMember 2022-06-30 0000927761 mymx:NoteEighteenMember 2022-06-30 0000927761 mymx:NoteSeventeenMember 2022-06-30 0000927761 mymx:NoteSixteenMember 2022-06-30 0000927761 mymx:NoteFiftteenMember 2022-06-30 0000927761 mymx:NoteFourteenMember 2022-06-30 0000927761 mymx:NoteThirteenMember 2022-06-30 0000927761 mymx:NoteTwevleMember 2022-06-30 0000927761 mymx:NoteElevenMember 2022-06-30 0000927761 mymx:NoteTenMember 2022-06-30 0000927761 mymx:NoteNineMember 2022-06-30 0000927761 mymx:NoteEightMember 2022-06-30 0000927761 mymx:NoteSevenMember 2022-06-30 0000927761 mymx:NoteSixMember 2022-06-30 0000927761 mymx:NoteFiveMember 2022-06-30 0000927761 mymx:NoteFourMember 2022-06-30 0000927761 mymx:NoteThreeMember 2022-06-30 0000927761 mymx:NoteTwoMember 2022-06-30 0000927761 mymx:NoteOneMember 2022-06-30 0000927761 mymx:NoteFifySevenMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFifySixMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFiftyFiveMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFiftyFourMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFiftyThreeMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFiftyTwoMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFiftyOneMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFiftyMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFortyNineMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFortyEightMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFortySevenMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFortySixMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFortyFiveMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFortyFourMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFortyThreeMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFortyTwoMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFortyOneMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFortyMember 2022-01-01 2022-06-30 0000927761 mymx:NoteThrityNineMember 2022-01-01 2022-06-30 0000927761 mymx:NoteThrityEightMember 2022-01-01 2022-06-30 0000927761 mymx:NoteThritySevenMember 2022-01-01 2022-06-30 0000927761 mymx:NoteThritySixMember 2022-01-01 2022-06-30 0000927761 mymx:NoteThrityFiveMember 2022-01-01 2022-06-30 0000927761 mymx:NoteThrityFourMember 2022-01-01 2022-06-30 0000927761 mymx:NoteThrityThreeMember 2022-01-01 2022-06-30 0000927761 mymx:NoteThrityTwoMember 2022-01-01 2022-06-30 0000927761 mymx:NoteThrityOneMember 2022-01-01 2022-06-30 0000927761 mymx:NoteThrityMember 2022-01-01 2022-06-30 0000927761 mymx:NoteTwentyNineMember 2022-01-01 2022-06-30 0000927761 mymx:NoteTwentyEightMember 2022-01-01 2022-06-30 0000927761 mymx:NoteTwentySevenMember 2022-01-01 2022-06-30 0000927761 mymx:NoteTwentySixMember 2022-01-01 2022-06-30 0000927761 mymx:NoteTwentyFiveMember 2022-01-01 2022-06-30 0000927761 mymx:NoteTwentyFourMember 2022-01-01 2022-06-30 0000927761 mymx:NoteTwentyThreeMember 2022-01-01 2022-06-30 0000927761 mymx:NoteTwentyTwoMember 2022-01-01 2022-06-30 0000927761 mymx:NoteTwentyOneMember 2022-01-01 2022-06-30 0000927761 mymx:NoteTwentyMember 2022-01-01 2022-06-30 0000927761 mymx:NoteNinteenMember 2022-01-01 2022-06-30 0000927761 mymx:NoteEighteenMember 2022-01-01 2022-06-30 0000927761 mymx:NoteSeventeenMember 2022-01-01 2022-06-30 0000927761 mymx:NoteSixteenMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFiftteenMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFourteenMember 2022-01-01 2022-06-30 0000927761 mymx:NoteThirteenMember 2022-01-01 2022-06-30 0000927761 mymx:NoteTwevleMember 2022-01-01 2022-06-30 0000927761 mymx:NoteElevenMember 2022-01-01 2022-06-30 0000927761 mymx:NoteTenMember 2022-01-01 2022-06-30 0000927761 mymx:NoteNineMember 2022-01-01 2022-06-30 0000927761 mymx:NoteEightMember 2022-01-01 2022-06-30 0000927761 mymx:NoteSevenMember 2022-01-01 2022-06-30 0000927761 mymx:NoteSixMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFiveMember 2022-01-01 2022-06-30 0000927761 mymx:NoteFourMember 2022-01-01 2022-06-30 0000927761 mymx:NoteThreeMember 2022-01-01 2022-06-30 0000927761 mymx:NoteTwoMember 2022-01-01 2022-06-30 0000927761 mymx:GrantRevenueMember 2021-01-01 2021-06-30 0000927761 mymx:GrantRevenueMember 2022-01-01 2022-06-30 0000927761 mymx:ThirdYearMember 2022-01-01 2022-06-30 0000927761 mymx:SecondYearMember 2022-01-01 2022-06-30 0000927761 mymx:FirstYearMember 2022-01-01 2022-06-30 0000927761 mymx:StockOptionsMember 2021-01-01 2021-06-30 0000927761 mymx:NoteOneMember 2022-01-01 2022-06-30 0000927761 mymx:StockOptionsMember 2022-01-01 2022-06-30 0000927761 mymx:NoteOneMember 2021-01-01 2021-06-30 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000927761 us-gaap:RetainedEarningsMember 2022-06-30 0000927761 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000927761 us-gaap:CommonStockMember 2022-06-30 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0000927761 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000927761 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000927761 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000927761 2022-03-31 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000927761 us-gaap:RetainedEarningsMember 2022-03-31 0000927761 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000927761 us-gaap:CommonStockMember 2022-03-31 0000927761 2022-01-01 2022-03-31 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000927761 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000927761 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000927761 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000927761 us-gaap:RetainedEarningsMember 2021-12-31 0000927761 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000927761 us-gaap:CommonStockMember 2021-12-31 0000927761 2021-06-30 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000927761 us-gaap:RetainedEarningsMember 2021-06-30 0000927761 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000927761 us-gaap:CommonStockMember 2021-06-30 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0000927761 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000927761 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000927761 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000927761 2021-03-31 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000927761 us-gaap:RetainedEarningsMember 2021-03-31 0000927761 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000927761 us-gaap:CommonStockMember 2021-03-31 0000927761 2021-01-01 2021-03-31 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000927761 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000927761 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000927761 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000927761 2020-12-31 0000927761 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000927761 us-gaap:RetainedEarningsMember 2020-12-31 0000927761 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000927761 us-gaap:CommonStockMember 2020-12-31 0000927761 2021-01-01 2021-06-30 0000927761 2021-04-01 2021-06-30 0000927761 2022-04-01 2022-06-30 0000927761 2021-12-31 0000927761 2022-06-30 0000927761 2022-08-11 iso4217:EUR iso4217:USD shares iso4217:EUR shares pure 0000927761 false --12-31 Q2 2022

0.01

1200000000

303757622

0.01

5000000

758730472 758730472 758730472

747880794

303757622

10-Q true 2022-06-30 false 000-25132 MYMETICS CORPORATION DE 25-1741849 c/o Ernie Stern 1101 Pennsylvania Avenue, N.W Suite 300 Washington D.C. US 20004 011 41 21 653 4535 Common Stock, Par Value $0.01 per share MYMX Yes Yes Non-accelerated Filer true false false 303757622

350000

571000

54000

15000

44000

87000

448000

673000

10000

480000

474000

33000

39000

186000

239000

6671000

7348000

7632000

78000

47000

15000

106000

110000

9495000

8790000

60036000

58479000

69730000

67426000

169000

162000

83000

130000

252000

292000

69982000

67718000

0.01

1200000000

303757622

2530000

0.01

5000000

34443000

-100303000

-97750000

696000

691000

-62634000

-60086000

7348000

7632000

3000

297000 159000 779000 290000

3000

297000

159000

782000

293000

400000

308000

982000

562000

327000

277000

659000

568000

727000

585000

1641000

1130000

-430000

-426000

-859000

-837000

699000

684000

1393000

1369000

-213000

22000

-301000

-100000

-1342000

-1088000

-2553000

-2306000

0 14000 0 42000

-1342000

-1102000

-2553000

-2348000

-2000

1000

5000

-7000

-1344000

-1101000

-2548000

-2355000

-0.00 -0.00 -0.01 -0.01 303757622000 303757622000 303757622000 303757622000

303757622000

2530000

34443000

-93020000

695000

-55352000

-1246000

0 0 0 -8000 -8000

303757622000

2530000

34443000

-94266000

687000

-56606000

-1102000

0 0 0 1000 1000

303757622000

2530000

34443000

-95368000

688000

-57707000

303757622000

2530000

34443000

-97750000

691000

-60086000

-1211000

0 0 0 7000 7000

303757622000

2530000

34443000

-98961000

698000

-61290000

-1342000

0 0 0 -2000 -2000

303757622000

2530000

34443000

-100303000

696000

-62634000

2553000

2348000

8000

9000

39000

-15000

1557000

1370000

105000 88000

31000

-14000

15000

36000

-52000

-46000

-824000

-798000

2000

10000

-2000

-10000

600000

5000

-7000

-221000

-815000

571000

1083000

350000

268000

38000

Note 1. The Company and Summary of Significant Accounting Policies BASIS OF PRESENTATION AND GOING CONCERN The amounts in the notes are shown in thousands of EURO, unless otherwise noted, and rounded to the nearest thousand except for share and per share amounts. The accompanying interim period condensed consolidated financial statements of Mymetics Corporation (the “Company”) set forth herein have been prepared by the Company pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosure normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such SEC rules and regulations. The interim period condensed consolidated financial statements should be read together with the audited financial statements and the accompanying notes included in the Company’s latest annual report on Form 10-K for the fiscal year ended December 31, 2021. The accompanying financial statements of the Company are unaudited. However, in the opinion of the Company, the unaudited condensed consolidated financial statements contained herein contain all adjustments necessary to present a fair statement of the results of the interim periods presented. All adjustments made during the three and six-month period ending June 30, 2022 were of a normal and recurring nature. The Company was created for the purpose of engaging in vaccine research and development. Its main research efforts in the beginning have been concentrated in the prevention and treatment of the AIDS virus and malaria. The Company has established a network which enables it to work with education centers, research centers, pharmaceutical laboratories and biotechnology companies. Besides the HIV and malaria vaccine candidates, the Company additionally has generated preclinical data for the following vaccines: Herpes Simplex and Respiratory Syncytial Virus (“RSV”), neither of which is currently being developed. The company also has clinical data for an intranasal influenza vaccine for the elderly which has finished a Phase I clinical trial and is currently on hold. As of June 30, 2022, the Company is working on several research projects for immunotherapy in the field oncology and for some infectious diseases with academic partners. Since April 2020, the Company has additionally started to work on the development of a intranasal virosome-based vaccine to prevent Covid-19, the disease caused by the SARS-CoV-2 virus. For the Covid-19 vaccine candidates, the Company is collaborating with leading academic institutions, such as Baylor College of Medicine in Texas, the Amsterdam Medical Center (AMC) of the University of Amsterdam in the Netherlands and the University Hospital in Bern, Switzerland. As of June 30, 2022, the Company was engaged in the pre-clinical testing of some of its vaccine candidates, but a commercially viable product is not expected for several more years. However, the Company generated some revenue through collaboration and grant agreements. These consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced negative cash flows from operations and significant losses since inception resulting in an accumulated deficit of €100,303 at June 30, 2022. Further, the Company’s current liabilities exceed its current assets by €69,282 as of June 30, 2022, and there is no assurance that cash will become available to pay current liabilities in the near term. Management is seeking additional financing but there can be no assurance that management will be successful in any of those efforts. These conditions raise substantial doubt about our ability to continue as a going concern within one year from the issuance of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. LEASES Effective January 1, 2019, the Company adopted ASC 842, which established a right-of-use (“ROU”) model requiring lessees to record a right-of-use (“ROU”) asset and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease, the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding right-of- use (“ROU”) asset. Lease liabilities represent the present value of our future lease payments over the expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company’s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.IMPACT OF THE NOVEL CORONAVIRUS On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus originating in Wuhan, China (the “COVID-19 outbreak”) and the risks to the international community as the virus spreads globally beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The COVID-19 pandemic has continued to evolve. Although at this date the restrictive measures and impacts are reduced due to the role out of vaccination programs, the extent to which the outbreak impacts our business, preclinical studies and clinical trials will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, the duration of the pandemic, travel restrictions and social distancing, business closures or business disruptions and the effectiveness of actions taken in the U.S., Europe, and other countries to contain and treat the disease. As such, it is uncertain as to the full magnitude that the pandemic will have on the Company’s financial condition, liquidity, and future results of operations. Management has taken measures in-line with the country requirements where we are operating, and we are actively monitoring the global situation on its financial condition, liquidity, operations, scientific collaborations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2022. The Company is dependent on its workforce to deliver and advance its research. Developments such as physical distancing and working from home directives have and will continue to impact the Company’s ability to deploy its workforce effectively. While restrictions are being lifted across the world, prolonged workforce disruptions may negatively impact future revenues for the remainder of fiscal year 2022 and the Company’s overall liquidity. The Company is dependent on its partners in certain projects, such as the University of Louisiana at Lafayette (“ULL”) for the NIH funded project to maintain the agreed timelines and execute their tasks. Developments such as social distancing and shelter-in-place directives and lock-down directives have and will continue to impact the Company’s ability to execute on project plans and research objectives effectively. While expected to be temporary, prolonged disruptions in collaboration projects may negatively impact funding for the fiscal year 2022 and the Company’s overall liquidity. Although the Company cannot estimate the length or gravity of the impact of the COVID-19 outbreak at this time, if the pandemic continues, it may have a material adverse effect on the Company’s results of future operations, financial position, and liquidity for the fiscal year 2022. CORONAVIRUS AID, RELIEF AND ECONOMIC SECURITY ACT On March 27, 2020, the U.S. Government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into law. The CARES Act includes various income and payroll tax provisions. The Company has analyzed the tax provisions of the CARES Act and determined they have no significant financial impact to the condensed financial statements. The Company has no intention of taking advantage of other benefits provided by the CARES Act but will continue to evaluate the impact on the Company’s financial position. PRINCIPLES OF CONSOLIDATION The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. Significant intercompany accounts and transactions have been eliminated.NEW ACCOUNTING PRONOUNCEMENT In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. Specifically, ASU 2020-06 simplifies accounting for the issuance of convertible instruments by removing major separation models required under current GAAP. In addition, the ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and simplifies the diluted earnings per share (EPS) calculation in certain areas. ASU 2020-06 will be effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, beginning in fiscal years which begin after December 15, 2020. The FASB has specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company is currently evaluating the impact of the pending adoption of this new standard on its consolidated financial statements. FOREIGN CURRENCY TRANSLATION The Company translates non-Euro assets and liabilities of its subsidiaries at the rate of exchange at the balance sheet date. Revenues and expenses are translated at the average rate of exchange throughout the period. Unrealized gains or losses from these translations are reported as a separate component of comprehensive income. Transaction gains or losses are included in foreign exchange (gain) loss in the consolidated statements of comprehensive loss. The translation adjustments do not recognize the effect of income tax because the Company expects to reinvest the amounts indefinitely in operations. The Company’s reporting currency is the Euro because substantially all of the Company’s activities are conducted in Europe. CASH The Company consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents. Cash deposits are occasionally in excess of insured amounts. REVENUE RECOGNITION Effective January 1, 2018, the Company adopted Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers, using the modified retrospective method and there was no impact to financial position and results of operations as a result of the adoption. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under Topic 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of Topic 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Overall, adoption of the new standard did not result in an adjustment to amounts previously reported in our consolidated financial statements and there were no other significant changes impacting the timing or measurement of our revenue or our business processes and controls. The Company has concluded that government grants are not within the scope of Topic 606, as they do not meet the definition of a contract with a “customer”. The Company concluded the definition of a contract with a “customer” was not met as the counterparty to the government grants has not contracted to obtain goods or services and thus the contracts are not considered to have commercial substance. Government grants provide the Company with payments for certain types of expenditures related to research and development activities over a contractually defined period. Revenue from government grants is recognized in the period during which the related costs are incurred, provided that the applicable conditions under the government contracts have been met. NIH On April 29, 2019, the National Institutes of Health (“NIH”) awarded the Company and Texas Biomedical Research Institute (“Texas Biomed”) a five-year grant for the project called “Cold Chain-independent, Needle-free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels” (“NIH Grant”). The project started on May 1, 2019 and is planned for five years. It was initially co-led by Texas Biomed, but due to the move of Dr. Ruth Ruprecht, the Co-Principal Investigator, to the University of Louisiana at Lafayette (“ULL”) at the end of 2019, ULL has become the co-lead with Mymetics for this project. The overall budget related to the project is US$8,850 with US$1,940 approved for the first year, US$1,856 approved for the second year, and US$1,720 for the third year. In April 2022, the Company filed a report to the NIH in collaboration with ULL, to validate funds for the fifth year of the ongoing HIV project (May 2022 to April 2023). The funds for the fourth year were approved in May 2022 with a total budget of US$ 1,616.The amounts mentioned in the following statements are purely related to the Company and not to the other partners in the project: The overall portion of the grant allocated to the Company is US$5,930, with US$1,190 approved for the first year, US$1,052 for the second year, US$ 1,078 for the third year and US$1,328 approved in June 2022 for the fourth year. The cost incurred and granted under the sub-award with Texas Biomed for the period of May to December 2019 was US$547 (€542). The sub-award contract between ULL and the Company for the period of January 2020 to April 2021, was signed for a total budget of US$870 and US$1,078 for the period May 2021 to April 2022. The total grant revenue incurred as of today is US$2,666 (€2,527), of which US$842 (€779) has been incurred during the six-months ended June 30, 2022. First results are expected to be reported in 2023. The project has the objective to prepare the Company’s promising HIV-1 vaccine candidate for clinical trials, by first executing a non-human primate (“NHP”) study, where the test subjects will be receiving Mymetics’ virosome based HIV-1 vaccine candidate by several intra-muscular and intra-nasal applications, followed by rectal challenges. As of June 30, 2022, Mymetics has successfully produced five sets of virosome based vaccines and the NHPs have received two intramuscular vaccinations and three intranasal vaccinations in two different studies. The vaccinations were well tolerated. These studies are ongoing. The vaccine is created to induce protective mucosal antibodies acting as a frontline defense against sexual HIV transmission. This awarded grant from the NIH will allow the Company to continue some of the developments that were achieved during the European Horizon 2020 project. In February 2022, Mymetics announced the publication of results in Frontiers in Immunology with title: “Cooperation between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques against Mucosal SHIV challenges”. Option to License Agreement – ANERGIS SA In April 2018 Mymetics engaged in a Research and Option to License Agreement with Anergis SA. Under the agreement, a mice proof-of-concept immunogenicity study evaluated the effects of the Bet v 1 COPs (Anergis’ proprietary birch pollen allergy peptides) using the five subcutaneous injection schedules used in former AllerT clinical trials. The development of AllerT (Bet v 1 COPs plus aluminum hydroxide) was discontinued by Anergis in 2017 following completion of a Phase 2 clinical trial showing evidence of sensitization to the peptides and a 7% reduction in seasonal allergy symptoms vs placebo (p=0.0047). In the mice study, AllerT was compared to Bet v 1 COPs linked to Mymetics’ virosomes (the “Bet v 1 COP-virosomes”). In December 2018 Anergis and Mymetics reported that the administration of AllerT led to the development of Bet v 1 specific IgEs (p<0.001) associated with a more pronounced TH2 than TH1 response. In contrast, in the mice receiving the Bet v 1 COP-virosomes, no development of Bet v 1 specific IgEs were observed (p<0.001 vs AllerT). With the same dose of Bet v 1 COPs, there was a strong boost of immunogenicity with a TH1 antibody response, which was a hundred times greater than with aluminum hydroxide (p<0.001). The Bet v 1 COP-virosomes were well tolerated. The success criteria were met and Anergis had a time limited option to enter into an exclusive license agreement with Mymetics for the use of virosomes in the field of allergies. In October 2019, Mymetics announced that Anergis SA started a new study with Stallergenes Greer SA whereby the COP-Virosomes were tested in the therapeutic mouse model of birch allergy in comparison with positive controls, i.e., birch allergen and birch pollen extract. This model has been confirmed as having predictive value towards the future clinical efficacy of new AIT treatment candidates. In May 2020, Mymetics announced the results of the study with Stallergenes Greer, a worldwide leader in allergen immunotherapy (AIT) and Anergis, a leader in ultra-fast AIT research and development. The results showed that a treatment with COP-virosomes was able to cure allergic asthma in birch pollen sensitized mice and that the COP-virosomes were significantly superior to the COP or the virosome alone, confirming the synergy between COP and virosomes to foster an improved second-generation AIT treatment. In January 2021, following the two successful studies with its virosome platform, Mymetics announced the acceptance of its joint publication in the scientific journal Clinical & Experimental Allergy with Stallergenes Greer SA and Anergis SA, with the title: Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice. As of February 1, 2021, Anergis SA has entered into liquidation since it was not able to raise sufficient funds to continue to operate. As of June 17, 2022, Anergis SA has entered into bankruptcy proceedings. RECEIVABLES Receivables are stated at their outstanding principal balances. Management reviews the collectability of receivables on a periodic basis and determines the appropriate amount of any allowance. There was no allowance necessary at June 30, 2022 or December 31, 2021. The Company writes off receivables to the allowance when management determines that a receivable is not collectible. The Company may retain a security interest in the products sold.PROPERTY AND EQUIPMENT Property and equipment is recorded at cost and is depreciated over its estimated useful life on straight-line basis from the date placed in service. Estimated useful lives are usually taken as three years. IMPAIRMENT OF LONG-LIVED ASSETS Long-lived assets, which include property and equipment, are assessed for impairment whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. The impairment testing involves comparing the carrying amount to the forecasted undiscounted future cash flows generated by that asset. In the event the carrying value of the assets exceeds the undiscounted future cash flows generated by that asset and the carrying value is not considered recoverable, impairment exists. An impairment loss is measured as the excess of the asset’s carrying value over its fair value, calculated using a discounted future cash flow method. An impairment loss would be recognized in net income (loss) in the period that the impairment occurs. GOODWILL Goodwill represents the excess of purchase price over the value assigned to the net tangible and identifiable intangible assets of a business acquired. The Company typically performs its annual goodwill impairment test effective as of April 1 of each year, unless events or circumstances indicate impairment may have occurred before that time. The Company assesses qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. After assessing qualitative factors, the Company determined that no further testing was necessary. If further testing was necessary, the Company would determine the fair value of each reporting unit and compare the fair value to the reporting unit’s carrying amount. The Company has one reporting unit. RESEARCH AND DEVELOPMENT Research and development costs are expensed as incurred. WITHHOLDING TAXES On March 10, 2021, the Swiss Federal tax administration conducted a withholding tax audit on Mymetics SA’s financial statements for the years 2015 to 2019. At the end of the tax audit, the tax inspector concluded that a portion of the intercompany interest expenses related to the subordinated loan from Mymetics Corporation to Mymetics SA could be considered as a hidden dividend distribution and therefore subject to Swiss withholding tax. The tax inspector encouraged the Company to file the relevant Swiss withholding tax forms to benefit from the double tax treaty between Switzerland and the United States. All required documentation has been sent, assessed and approved by the Swiss Federal tax administration. The portion of the intercompany interest expenses related to the subordinated loan from Mymetics Corporation to Mymetics SA is considered as a hidden dividend distribution and therefore subject to Swiss withholding tax at a reduced tax rate of 5% and based on the double tax treaty in force between Switzerland and the United State of America. All required tax declaration forms have been filed and the related withholding tax amounts have been accounted for as of December 31, 2021. TAXES ON INCOME The Company accounts for income taxes under an asset and liability approach that requires the recognition of deferred tax assets and liabilities for expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. In estimating future tax consequences, the Company generally considers all expected future events other than enactments of changes in the tax laws or rates. The Company reports a liability, if any, for unrecognized tax benefits resulting from uncertain income tax positions taken or expected to be taken in an income tax return. Estimated interest and penalties, if any, are recorded as a component of interest expense and other expense, respectively. The Company has not recorded any liabilities for uncertain tax positions or any related interest and penalties at June 30, 2022 nor December 31, 2021. The Company’s United States tax returns are open to audit for the years ended December 31, 2015 to 2019. The returns for the Swiss subsidiary, Mymetics S.A., are open to audit for the year ended December 31, 2021. The returns for the Netherlands subsidiaries, Bestewil B.V. and Mymetics B.V., are open to audit for the year ended December 31, 2021.EARNINGS PER SHARE Basic earnings per share is computed by dividing net income or loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. Diluted earnings per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities. For the periods ended June 30, 2022 and 2021, options and convertible debt were not included in the computation of diluted earnings per share because their effect would be anti-dilutive due to net losses incurred under the treasury stock method. For the three and six months ended June 30, 2022, the basic weighted and diluted average number of shares was 303,757,622. The total potential number of shares issuable of 784,480,472 at June 30, 2022 includes 758,730,472 potential issuable shares related to convertible loans, and 25,750,000 potential issuable shares related to outstanding stock options granted to employees. For the three and six months ended June 30, 2021, the basic weighted and diluted average number of shares was 303,757,622. The total potential number of shares issuable of 747,880,794 at June 30, 2021 includes 722,130,794 potential issuable shares related to convertible loans, and 25,750,000 potential issuable shares related to outstanding stock options granted to employees. PREFERRED STOCK The Company has authorized 5,000,000 shares of preferred stock that may be issued in several series with varying dividend, conversion and voting rights. No preferred shares are issued or outstanding at June 30, 2022 or December 31, 2021. ESTIMATES The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. FAIR VALUE MEASUREMENTS Fair value guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: <table cellpadding="0" style="border-spacing:0;font-size:10pt;text-align:left;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"> </td><td style="width:6%;">Level 1-</td><td>Quoted prices in active markets for identical assets or liabilities.</td></tr><tr style="height:15px"><td> </td><td>Level 2-</td><td>Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated byobservable market data for substantially the full term of the assets or liabilities.</td></tr><tr style="height:15px"><td> </td><td style="vertical-align:top;">Level 3-</td><td>Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of theassets or liabilities.</td></tr></tbody></table> FAIR VALUES OF FINANCIAL INSTRUMENTS The Company generally has the following financial instruments: cash, receivables, accounts payable, and notes payable. The carrying value of cash, accounts receivable, and accounts payable, approximates their fair value based on the short-term nature of these financial instruments. Management believes the fair value of the note’s payable is reflecting the actual value reported for these instruments. CONCENTRATIONS The Company derived 100% and 99% of grant revenue for the six-month periods ended June 30, 2022 and 2021, from one grantor, respectively. For the period ended December 31, 2021, the Company derived 99% of grant revenue from one partner. RELATED PARTY TRANSACTIONS Mr. Ernest M. Stern, the Company’s outside U.S. counsel, is both a director of the Company and is a partner in Culhane Meadows PLLC, the firm retained as legal counsel by the Company. The Company incurred professional fees to the counsel’s law firms totaling €27 and €3 for the three months ended June 30, 2022 and 2021 respectively; and €33 and €14 for the six months ended June 30, 2022 and 2021, respectively.Two of the Company’s major shareholders have granted secured convertible notes and short-term convertible notes and promissory notes, which have a total carrying amount of €69,073 including interest due as of June 30, 2022. Conversion prices on the Euro-denominated convertible debt have been fixed to a fixed Euro/US dollar exchange rate.

The amounts in the notes are shown in thousands of EURO, unless otherwise noted, and rounded to the nearest thousand except for share and per share amounts. The accompanying interim period condensed consolidated financial statements of Mymetics Corporation (the “Company”) set forth herein have been prepared by the Company pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosure normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such SEC rules and regulations. The interim period condensed consolidated financial statements should be read together with the audited financial statements and the accompanying notes included in the Company’s latest annual report on Form 10-K for the fiscal year ended December 31, 2021. The accompanying financial statements of the Company are unaudited. However, in the opinion of the Company, the unaudited condensed consolidated financial statements contained herein contain all adjustments necessary to present a fair statement of the results of the interim periods presented. All adjustments made during the three and six-month period ending June 30, 2022 were of a normal and recurring nature. The Company was created for the purpose of engaging in vaccine research and development. Its main research efforts in the beginning have been concentrated in the prevention and treatment of the AIDS virus and malaria. The Company has established a network which enables it to work with education centers, research centers, pharmaceutical laboratories and biotechnology companies. Besides the HIV and malaria vaccine candidates, the Company additionally has generated preclinical data for the following vaccines: Herpes Simplex and Respiratory Syncytial Virus (“RSV”), neither of which is currently being developed. The company also has clinical data for an intranasal influenza vaccine for the elderly which has finished a Phase I clinical trial and is currently on hold. As of June 30, 2022, the Company is working on several research projects for immunotherapy in the field oncology and for some infectious diseases with academic partners. Since April 2020, the Company has additionally started to work on the development of a intranasal virosome-based vaccine to prevent Covid-19, the disease caused by the SARS-CoV-2 virus. For the Covid-19 vaccine candidates, the Company is collaborating with leading academic institutions, such as Baylor College of Medicine in Texas, the Amsterdam Medical Center (AMC) of the University of Amsterdam in the Netherlands and the University Hospital in Bern, Switzerland. As of June 30, 2022, the Company was engaged in the pre-clinical testing of some of its vaccine candidates, but a commercially viable product is not expected for several more years. However, the Company generated some revenue through collaboration and grant agreements. These consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced negative cash flows from operations and significant losses since inception resulting in an accumulated deficit of €100,303 at June 30, 2022. Further, the Company’s current liabilities exceed its current assets by €69,282 as of June 30, 2022, and there is no assurance that cash will become available to pay current liabilities in the near term. Management is seeking additional financing but there can be no assurance that management will be successful in any of those efforts. These conditions raise substantial doubt about our ability to continue as a going concern within one year from the issuance of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

-100303000

69282

Effective January 1, 2019, the Company adopted ASC 842, which established a right-of-use (“ROU”) model requiring lessees to record a right-of-use (“ROU”) asset and lease obligations on the balance sheet for all leases with terms longer than 12 months. The Company determines if an arrangement is a lease at inception. Where an arrangement is a lease, the Company determines if it is an operating lease or a finance lease. At lease commencement, the Company records a lease liability and corresponding right-of- use (“ROU”) asset. Lease liabilities represent the present value of our future lease payments over the expected lease term which includes options to extend or terminate the lease when it is reasonably certain those options will be exercised. The present value of the Company’s lease liability is determined using its incremental collateralized borrowing rate at lease inception. ROU assets represent its right to control the use of the leased asset during the lease and are recognized in an amount equal to the lease liability for leases with an initial term greater than 12 months. Over the lease term (operating leases only), the Company uses the effective interest rate method to account for the lease liability as lease payments are made and the ROU asset is amortized to consolidated statement of operations in a manner that results in straight-line expense recognition. The Company does not apply lease recognition requirements for short-term leases. Instead, the Company recognizes payments related to these arrangements in the consolidated statement of operations as lease costs on a straight-line basis over the lease term.

On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus originating in Wuhan, China (the “COVID-19 outbreak”) and the risks to the international community as the virus spreads globally beyond its point of origin. In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The COVID-19 pandemic has continued to evolve. Although at this date the restrictive measures and impacts are reduced due to the role out of vaccination programs, the extent to which the outbreak impacts our business, preclinical studies and clinical trials will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, the duration of the pandemic, travel restrictions and social distancing, business closures or business disruptions and the effectiveness of actions taken in the U.S., Europe, and other countries to contain and treat the disease. As such, it is uncertain as to the full magnitude that the pandemic will have on the Company’s financial condition, liquidity, and future results of operations. Management has taken measures in-line with the country requirements where we are operating, and we are actively monitoring the global situation on its financial condition, liquidity, operations, scientific collaborations, suppliers, industry, and workforce. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2022. The Company is dependent on its workforce to deliver and advance its research. Developments such as physical distancing and working from home directives have and will continue to impact the Company’s ability to deploy its workforce effectively. While restrictions are being lifted across the world, prolonged workforce disruptions may negatively impact future revenues for the remainder of fiscal year 2022 and the Company’s overall liquidity. The Company is dependent on its partners in certain projects, such as the University of Louisiana at Lafayette (“ULL”) for the NIH funded project to maintain the agreed timelines and execute their tasks. Developments such as social distancing and shelter-in-place directives and lock-down directives have and will continue to impact the Company’s ability to execute on project plans and research objectives effectively. While expected to be temporary, prolonged disruptions in collaboration projects may negatively impact funding for the fiscal year 2022 and the Company’s overall liquidity. Although the Company cannot estimate the length or gravity of the impact of the COVID-19 outbreak at this time, if the pandemic continues, it may have a material adverse effect on the Company’s results of future operations, financial position, and liquidity for the fiscal year 2022. On March 27, 2020, the U.S. Government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was signed into law. The CARES Act includes various income and payroll tax provisions. The Company has analyzed the tax provisions of the CARES Act and determined they have no significant financial impact to the condensed financial statements. The Company has no intention of taking advantage of other benefits provided by the CARES Act but will continue to evaluate the impact on the Company’s financial position.

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. Significant intercompany accounts and transactions have been eliminated.

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. Specifically, ASU 2020-06 simplifies accounting for the issuance of convertible instruments by removing major separation models required under current GAAP. In addition, the ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and simplifies the diluted earnings per share (EPS) calculation in certain areas. ASU 2020-06 will be effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, beginning in fiscal years which begin after December 15, 2020. The FASB has specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company is currently evaluating the impact of the pending adoption of this new standard on its consolidated financial statements.

The Company translates non-Euro assets and liabilities of its subsidiaries at the rate of exchange at the balance sheet date. Revenues and expenses are translated at the average rate of exchange throughout the period. Unrealized gains or losses from these translations are reported as a separate component of comprehensive income. Transaction gains or losses are included in foreign exchange (gain) loss in the consolidated statements of comprehensive loss. The translation adjustments do not recognize the effect of income tax because the Company expects to reinvest the amounts indefinitely in operations. The Company’s reporting currency is the Euro because substantially all of the Company’s activities are conducted in Europe.

The Company consider all highly liquid investments purchased with maturities of three months or less to be cash equivalents. Cash deposits are occasionally in excess of insured amounts.

Effective January 1, 2018, the Company adopted Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers, using the modified retrospective method and there was no impact to financial position and results of operations as a result of the adoption. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under Topic 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of Topic 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Overall, adoption of the new standard did not result in an adjustment to amounts previously reported in our consolidated financial statements and there were no other significant changes impacting the timing or measurement of our revenue or our business processes and controls. The Company has concluded that government grants are not within the scope of Topic 606, as they do not meet the definition of a contract with a “customer”. The Company concluded the definition of a contract with a “customer” was not met as the counterparty to the government grants has not contracted to obtain goods or services and thus the contracts are not considered to have commercial substance. Government grants provide the Company with payments for certain types of expenditures related to research and development activities over a contractually defined period. Revenue from government grants is recognized in the period during which the related costs are incurred, provided that the applicable conditions under the government contracts have been met.

On April 29, 2019, the National Institutes of Health (“NIH”) awarded the Company and Texas Biomedical Research Institute (“Texas Biomed”) a five-year grant for the project called “Cold Chain-independent, Needle-free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels” (“NIH Grant”). The project started on May 1, 2019 and is planned for five years. It was initially co-led by Texas Biomed, but due to the move of Dr. Ruth Ruprecht, the Co-Principal Investigator, to the University of Louisiana at Lafayette (“ULL”) at the end of 2019, ULL has become the co-lead with Mymetics for this project. The overall budget related to the project is US$8,850 with US$1,940 approved for the first year, US$1,856 approved for the second year, and US$1,720 for the third year. In April 2022, the Company filed a report to the NIH in collaboration with ULL, to validate funds for the fifth year of the ongoing HIV project (May 2022 to April 2023). The funds for the fourth year were approved in May 2022 with a total budget of US$ 1,616.The amounts mentioned in the following statements are purely related to the Company and not to the other partners in the project: The overall portion of the grant allocated to the Company is US$5,930, with US$1,190 approved for the first year, US$1,052 for the second year, US$ 1,078 for the third year and US$1,328 approved in June 2022 for the fourth year. The cost incurred and granted under the sub-award with Texas Biomed for the period of May to December 2019 was US$547 (€542). The sub-award contract between ULL and the Company for the period of January 2020 to April 2021, was signed for a total budget of US$870 and US$1,078 for the period May 2021 to April 2022. The total grant revenue incurred as of today is US$2,666 (€2,527), of which US$842 (€779) has been incurred during the six-months ended June 30, 2022. First results are expected to be reported in 2023. The project has the objective to prepare the Company’s promising HIV-1 vaccine candidate for clinical trials, by first executing a non-human primate (“NHP”) study, where the test subjects will be receiving Mymetics’ virosome based HIV-1 vaccine candidate by several intra-muscular and intra-nasal applications, followed by rectal challenges. As of June 30, 2022, Mymetics has successfully produced five sets of virosome based vaccines and the NHPs have received two intramuscular vaccinations and three intranasal vaccinations in two different studies. The vaccinations were well tolerated. These studies are ongoing. The vaccine is created to induce protective mucosal antibodies acting as a frontline defense against sexual HIV transmission. This awarded grant from the NIH will allow the Company to continue some of the developments that were achieved during the European Horizon 2020 project. In February 2022, Mymetics announced the publication of results in Frontiers in Immunology with title: “Cooperation between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques against Mucosal SHIV challenges”. Option to License Agreement – ANERGIS SA In April 2018 Mymetics engaged in a Research and Option to License Agreement with Anergis SA. Under the agreement, a mice proof-of-concept immunogenicity study evaluated the effects of the Bet v 1 COPs (Anergis’ proprietary birch pollen allergy peptides) using the five subcutaneous injection schedules used in former AllerT clinical trials. The development of AllerT (Bet v 1 COPs plus aluminum hydroxide) was discontinued by Anergis in 2017 following completion of a Phase 2 clinical trial showing evidence of sensitization to the peptides and a 7% reduction in seasonal allergy symptoms vs placebo (p=0.0047). In the mice study, AllerT was compared to Bet v 1 COPs linked to Mymetics’ virosomes (the “Bet v 1 COP-virosomes”). In December 2018 Anergis and Mymetics reported that the administration of AllerT led to the development of Bet v 1 specific IgEs (p<0.001) associated with a more pronounced TH2 than TH1 response. In contrast, in the mice receiving the Bet v 1 COP-virosomes, no development of Bet v 1 specific IgEs were observed (p<0.001 vs AllerT). With the same dose of Bet v 1 COPs, there was a strong boost of immunogenicity with a TH1 antibody response, which was a hundred times greater than with aluminum hydroxide (p<0.001). The Bet v 1 COP-virosomes were well tolerated. The success criteria were met and Anergis had a time limited option to enter into an exclusive license agreement with Mymetics for the use of virosomes in the field of allergies. In October 2019, Mymetics announced that Anergis SA started a new study with Stallergenes Greer SA whereby the COP-Virosomes were tested in the therapeutic mouse model of birch allergy in comparison with positive controls, i.e., birch allergen and birch pollen extract. This model has been confirmed as having predictive value towards the future clinical efficacy of new AIT treatment candidates. In May 2020, Mymetics announced the results of the study with Stallergenes Greer, a worldwide leader in allergen immunotherapy (AIT) and Anergis, a leader in ultra-fast AIT research and development. The results showed that a treatment with COP-virosomes was able to cure allergic asthma in birch pollen sensitized mice and that the COP-virosomes were significantly superior to the COP or the virosome alone, confirming the synergy between COP and virosomes to foster an improved second-generation AIT treatment. In January 2021, following the two successful studies with its virosome platform, Mymetics announced the acceptance of its joint publication in the scientific journal Clinical & Experimental Allergy with Stallergenes Greer SA and Anergis SA, with the title: Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice. As of February 1, 2021, Anergis SA has entered into liquidation since it was not able to raise sufficient funds to continue to operate. As of June 17, 2022, Anergis SA has entered into bankruptcy proceedings. The overall budget related to the project is US$8,850 with US$1,940 approved for the first year, US$1,856 approved for the second year, and US$1,720 for the third year. In April 2022, the Company filed a report to the NIH in collaboration with ULL, to validate funds for the fifth year of the ongoing HIV project (May 2022 to April 2023). The funds for the fourth year were approved in May 2022 with a total budget of US$ 1,616. The amounts mentioned in the following statements are purely related to the Company and not to the other partners in the project: The overall portion of the grant allocated to the Company is US$5,930, with US$1,190 approved for the first year, US$1,052 for the second year, US$ 1,078 for the third year and US$1,328 approved in June 2022 for the fourth year. 547 542 870 1078 2666 2527 842 779

Receivables are stated at their outstanding principal balances. Management reviews the collectability of receivables on a periodic basis and determines the appropriate amount of any allowance. There was no allowance necessary at June 30, 2022 or December 31, 2021. The Company writes off receivables to the allowance when management determines that a receivable is not collectible. The Company may retain a security interest in the products sold.

Property and equipment is recorded at cost and is depreciated over its estimated useful life on straight-line basis from the date placed in service. Estimated useful lives are usually taken as three years.

Long-lived assets, which include property and equipment, are assessed for impairment whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. The impairment testing involves comparing the carrying amount to the forecasted undiscounted future cash flows generated by that asset. In the event the carrying value of the assets exceeds the undiscounted future cash flows generated by that asset and the carrying value is not considered recoverable, impairment exists. An impairment loss is measured as the excess of the asset’s carrying value over its fair value, calculated using a discounted future cash flow method. An impairment loss would be recognized in net income (loss) in the period that the impairment occurs.

Goodwill represents the excess of purchase price over the value assigned to the net tangible and identifiable intangible assets of a business acquired. The Company typically performs its annual goodwill impairment test effective as of April 1 of each year, unless events or circumstances indicate impairment may have occurred before that time. The Company assesses qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. After assessing qualitative factors, the Company determined that no further testing was necessary. If further testing was necessary, the Company would determine the fair value of each reporting unit and compare the fair value to the reporting unit’s carrying amount. The Company has one reporting unit.

Research and development costs are expensed as incurred.

On March 10, 2021, the Swiss Federal tax administration conducted a withholding tax audit on Mymetics SA’s financial statements for the years 2015 to 2019. At the end of the tax audit, the tax inspector concluded that a portion of the intercompany interest expenses related to the subordinated loan from Mymetics Corporation to Mymetics SA could be considered as a hidden dividend distribution and therefore subject to Swiss withholding tax. The tax inspector encouraged the Company to file the relevant Swiss withholding tax forms to benefit from the double tax treaty between Switzerland and the United States. All required documentation has been sent, assessed and approved by the Swiss Federal tax administration. The portion of the intercompany interest expenses related to the subordinated loan from Mymetics Corporation to Mymetics SA is considered as a hidden dividend distribution and therefore subject to Swiss withholding tax at a reduced tax rate of 5% and based on the double tax treaty in force between Switzerland and the United State of America. All required tax declaration forms have been filed and the related withholding tax amounts have been accounted for as of December 31, 2021.

The Company accounts for income taxes under an asset and liability approach that requires the recognition of deferred tax assets and liabilities for expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. In estimating future tax consequences, the Company generally considers all expected future events other than enactments of changes in the tax laws or rates. The Company reports a liability, if any, for unrecognized tax benefits resulting from uncertain income tax positions taken or expected to be taken in an income tax return. Estimated interest and penalties, if any, are recorded as a component of interest expense and other expense, respectively. The Company has not recorded any liabilities for uncertain tax positions or any related interest and penalties at June 30, 2022 nor December 31, 2021. The Company’s United States tax returns are open to audit for the years ended December 31, 2015 to 2019. The returns for the Swiss subsidiary, Mymetics S.A., are open to audit for the year ended December 31, 2021. The returns for the Netherlands subsidiaries, Bestewil B.V. and Mymetics B.V., are open to audit for the year ended December 31, 2021.

Basic earnings per share is computed by dividing net income or loss attributable to common shareholders by the weighted average number of common shares outstanding in the period. Diluted earnings per share takes into consideration common shares outstanding (computed under basic earnings per share) and potentially dilutive securities. For the periods ended June 30, 2022 and 2021, options and convertible debt were not included in the computation of diluted earnings per share because their effect would be anti-dilutive due to net losses incurred under the treasury stock method. For the three and six months ended June 30, 2022, the basic weighted and diluted average number of shares was 303,757,622. The total potential number of shares issuable of 784,480,472 at June 30, 2022 includes 758,730,472 potential issuable shares related to convertible loans, and 25,750,000 potential issuable shares related to outstanding stock options granted to employees. For the three and six months ended June 30, 2021, the basic weighted and diluted average number of shares was 303,757,622. The total potential number of shares issuable of 747,880,794 at June 30, 2021 includes 722,130,794 potential issuable shares related to convertible loans, and 25,750,000 potential issuable shares related to outstanding stock options granted to employees.

303757622

784480472

758730472

25750000

303757622

747880794

722130794

25750000

The Company has authorized 5,000,000 shares of preferred stock that may be issued in several series with varying dividend, conversion and voting rights. No preferred shares are issued or outstanding at June 30, 2022 or December 31, 2021.

5000000

The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Fair value guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: <table cellpadding="0" style="border-spacing:0;font-size:10pt;text-align:left;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"> </td><td style="width:6%;">Level 1-</td><td>Quoted prices in active markets for identical assets or liabilities.</td></tr><tr style="height:15px"><td> </td><td>Level 2-</td><td>Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated byobservable market data for substantially the full term of the assets or liabilities.</td></tr><tr style="height:15px"><td> </td><td style="vertical-align:top;">Level 3-</td><td>Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of theassets or liabilities.</td></tr></tbody></table>

The Company generally has the following financial instruments: cash, receivables, accounts payable, and notes payable. The carrying value of cash, accounts receivable, and accounts payable, approximates their fair value based on the short-term nature of these financial instruments. Management believes the fair value of the note’s payable is reflecting the actual value reported for these instruments.

The Company derived 100% and 99% of grant revenue for the six-month periods ended June 30, 2022 and 2021, from one grantor, respectively. For the period ended December 31, 2021, the Company derived 99% of grant revenue from one partner.

0.99

Mr. Ernest M. Stern, the Company’s outside U.S. counsel, is both a director of the Company and is a partner in Culhane Meadows PLLC, the firm retained as legal counsel by the Company. The Company incurred professional fees to the counsel’s law firms totaling €27 and €3 for the three months ended June 30, 2022 and 2021 respectively; and €33 and €14 for the six months ended June 30, 2022 and 2021, respectively.Two of the Company’s major shareholders have granted secured convertible notes and short-term convertible notes and promissory notes, which have a total carrying amount of €69,073 including interest due as of June 30, 2022. Conversion prices on the Euro-denominated convertible debt have been fixed to a fixed Euro/US dollar exchange rate.

69073

Note 2. Debt Financing Certain principal shareholders have granted the Company secured convertible notes (in accordance with the Uniform Commercial Code in the State of Delaware), short term convertible notes and other short-term notes, which have a total carrying value of €69,531 including interest due to date. Interest incurred on these notes since inception has been added to the principal amounts.The details of the convertible notes and loans are as follows at June 30, 2022: <table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:28%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td colspan="2" style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:7%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td colspan="2" style="width:2%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">Fixed</td><td style="width:1%;"> </td></tr><tr style="height:15px"><td style="width:28%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td colspan="2" style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:7%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td colspan="2" style="width:2%;"> </td><td style="width:8%;vertical-align:bottom;">Conversion</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">Rate</td><td style="width:1%;"> </td></tr><tr style="height:15px"><td style="width:28%;vertical-align:bottom;">Lender</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1st-Issue</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td colspan="2" style="width:8%;vertical-align:bottom;">Principal</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">Duration</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">Interest</td><td colspan="2" style="width:2%;"> </td><td style="width:8%;vertical-align:bottom;">Price</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">EUR/USD</td><td style="width:1%;"> </td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:28%;vertical-align:bottom;">Price</td><td style="width:1%;"> </td><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;">Date</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td colspan="2" style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;">Amount</td><td style="width:1%;"> </td><td style="BORDER-BOTTOM: 1px solid;width:7%;vertical-align:bottom;">(Note)</td><td style="width:1%;"> </td><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;">Rate</td><td colspan="2" style="width:2%;"> </td><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;">(stated)</td><td style="width:1%;"> </td><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;">Conversion</td><td style="width:1%;"> </td></tr><tr style="height:15px"><td style="width:28%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td colspan="2" style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:7%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td colspan="2" style="width:2%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G. (1)</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/23/2006</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:bottom;">€</td><td style="width:6%;vertical-align:bottom;">182</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.10</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Anglo Irish Bank S.A.(3)</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">10/21/2007</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">500</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.50</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4090</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">12/10/2007</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">1,500</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.50</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4429</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">01/22/2008</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">1,500</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.50</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4629</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">04/25/2008</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">2,000</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.50</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.5889</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/30/2008</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">1,500</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.50</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.5380</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">11/18/2008</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">1,200</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.50</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2650</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">02/09/2009</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">1,500</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.50</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2940</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/15/2009</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">5,500</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2,4</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.80</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4045</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/15/2009</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">100</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2,4</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.80</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4300</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Von Meyenburg</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">08/03/2009</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">200</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.80</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4400</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">10/13/2009</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">2,000</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">5% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.25</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4854</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">12/18/2009</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">2,200</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">5% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.25</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4338</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">08/04/2011</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">1,148</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(5,6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">08/04/2011</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">297</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(5,6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">11/08/2011</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">400</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3787</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">11/08/2011</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">100</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3787</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">02/10/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">1,000</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3260</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">02/14/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">200</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3260</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">04/19/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">322</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3100</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">04/19/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">80</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3100</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">05/04/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">480</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3152</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">05/04/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">120</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3152</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">09/03/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">200</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2576</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">09/03/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">50</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2576</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">11/14/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">500</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2718</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">12/06/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">125</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3070</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">01/16/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">240</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3318</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">01/16/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">60</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3318</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">03/25/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">400</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.037</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2915</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">04/14/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">150</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3056</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">04/14/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">600</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3056</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">05/15/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">170</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.037</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2938</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">05/15/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">680</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.037</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2938</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/24/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">60</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.025</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3340</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/24/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">240</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.025</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3340</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">08/05/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">80</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.018</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3283</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">08/05/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">320</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.018</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3283</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">03/01/2017</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">230</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(7</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">03/01/2017</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">920</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(7</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">10/18/2017</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">230</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(7</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">10/18/2017</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">920</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(7</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/01/2018</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">160</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(8</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/01/2018</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">640</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(8</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">11/10/2018</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">160</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(8</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">11/10/2018</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">640</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(8</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">06/15/2019</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">120</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(9</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">06/15/2019</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">480</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(9</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">12/20/2019</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">120</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(10</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">12/20/2019</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">480</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(10</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:top;">Eardley Holding AG</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">06/15/2020</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">220</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(11</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">06/15/2020</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">880</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(11</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:top;">Eardley Holding AG</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">12/15/2020</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">170</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(12</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">12/15/2020</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">680</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(12</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:top;">Eardley Holding AG</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">08/15/2021</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">240</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(13</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">08/15/2021</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">960</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(13</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:top;">Eardley Holding AG</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">04/30/2022</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">120</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(14</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">04/30/2022</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="BORDER-BOTTOM: 1px solid;width:2%;vertical-align:top;">€</td><td style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:top;">480</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(14</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Total Short Term Principal Amounts</td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">36,744</td><td style="width:1%;"> </td><td style="width:7%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Accrued Interest</td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="BORDER-BOTTOM: 1px solid;width:2%;vertical-align:top;">€</td><td style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;">32,787</td><td style="width:1%;"> </td><td style="width:7%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">TOTAL LOANS AND NOTES</td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="BORDER-BOTTOM: 3px double;width:2%;vertical-align:top;">€</td><td style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;">69,531</td><td style="width:1%;"> </td><td style="width:7%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td></tr></tbody></table> (1) Private investment company of Dr. Thomas Staehelin, member of the Board of Directors and of the Audit Committee of the Company. Face value is stated in U.S. dollars at $190.(2) This maturity date is automatically prolonged for periods of three months, unless called for repayment. (3) Renamed Hyposwiss Private Bank Genève S.A. and acting on behalf of Round Enterprises Ltd. which is a major shareholder. (4) The loan is secured against 2/3rds of the IP assets of Bestewil Holding BV and against all property of the Company. (5) The face values of the loans are stated in U.S. dollars at $1,200 and $300, respectively. (6) This maturity date is automatically prolonged for periods of three months, unless called for repayment. The conversion price per share is determined by the lower of (i) reducing by 10% the price per share of the Company’s common stock paid by the investors in connection with an investment in the Company of not less than US$20,000, or (ii) at the fixed conversion price using a fixed exchange rate which are noted in the table above. The convertible note holder has the right to convert at any time prior to the maturity date, at the convertible note holder’s option, prior to the repayment of the outstanding balance under the note by the Company, to convert the unpaid outstanding principal balance and accrued interest, in whole or in part, into common stock at the fixed conversion price as stated in the contract. (7) On March 1, 2017, Round Enterprises Ltd. and Eardley Holding AG each provided two promissory Notes for a total of €1,840 and €460, respectively, with a 2.5% interest per annum and a maturity date of March 1, 2018. The first 50% of the promissory Notes of €920 and €230, respectively, were provided immediately. The second 50% of the promissory notes of €920 and €230, respectively, were provided on October 18, 2017, with a 2.5% interest per annum and a maturity date of October 18, 2018. Both Round Enterprises Ltd. And Eardley Holding AG have agreed to amend the maturity date of these promissory notes to follow the same terms of the other convertible loans. Therefore, the maturity date of the promissory notes is amended to be the later of (i) June 30, 2018, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. The amendments were accounted for as modifications in the consolidated financial statements. (8) On June 1, 2018, Round Enterprises Ltd. and Eardley Holding AG each provided two promissory Notes for a total of €1,280 and €320 in two tranches, respectively, with a 2.5% interest per annum. The first tranche of the promissory Notes of €640 and €160, respectively, were provided immediately. The second tranche of the promissory notes of €640 and €160, respectively, were provided on November 10, 2018, with a 2.5% interest per annum. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2019, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. (9) On June 15, 2019, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €600 with a 2.5% interest per annum. The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. (10) On December 20, 2019, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €600 with a 2.5% interest per annum. The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.(11) On June 15, 2020, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €1,100 with a 2.5% interest per annum. The promissory Notes of €880 and €220, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. (12) On December 15, 2020, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €850 with a 2.5% interest per annum. The promissory Notes of €680 and €170, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) March 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. (13) On August 15, 2021, Round Enterprises Ltd. and Eardley Holding AG each provided promissory Notes for a total of €1,200 with a 2.5% interest per annum. The promissory Notes of €960 and €240, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. (14) On April 30, 2022, Round Enterprises Ltd. and Eardley Holding AG each provided two promissory Notes for a total of €960 and €240 in two tranches, respectively, with a 2.5% interest per annum. The first tranche of the promissory Notes of €480 and €120, respectively, were provided immediately. The second tranche of the promissory notes of €480 and €120, respectively, will be provided in August, 2022, with a 2.5% interest per annum. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2022, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes. On April 2, 2020, the Swiss entity, Mymetics SA, received a federal credit line of Chf168 (€156) in relation with the Covid-19 pandemic. This credit line applies for five years and is fully guaranteed by the Swiss Confederation via guaranteed organizations. The interest rate is currently at 0 percent until March 31, 2021. The Swiss Confederation has the right to adjust the interest rate to the market rate. The first revision took place as of April 1, 2021, but no modification was applied. A first amortization installment of €28 will be due on September 30, 2022. This installment is related to the period of March to September 2022. The next amortization of €14 will be due on March 31, 2023. The entire loan should be fully amortized by September 30, 2027. Certain of the secured convertible notes have conversion features that should be bifurcated from the debt and recorded at fair value; however, as of June 30, 2022, and December 31, 2021, the probability of the conversion features being exercised was zero. For this reason, the conversion features are not required to be bifurcated from the debt as the fair value is zero at June 30, 2022, and December 31, 2021.

69531000

<table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:28%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td colspan="2" style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:7%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td colspan="2" style="width:2%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">Fixed</td><td style="width:1%;"> </td></tr><tr style="height:15px"><td style="width:28%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td colspan="2" style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:7%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td colspan="2" style="width:2%;"> </td><td style="width:8%;vertical-align:bottom;">Conversion</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">Rate</td><td style="width:1%;"> </td></tr><tr style="height:15px"><td style="width:28%;vertical-align:bottom;">Lender</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1st-Issue</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td colspan="2" style="width:8%;vertical-align:bottom;">Principal</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">Duration</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">Interest</td><td colspan="2" style="width:2%;"> </td><td style="width:8%;vertical-align:bottom;">Price</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">EUR/USD</td><td style="width:1%;"> </td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:28%;vertical-align:bottom;">Price</td><td style="width:1%;"> </td><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;">Date</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td colspan="2" style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;">Amount</td><td style="width:1%;"> </td><td style="BORDER-BOTTOM: 1px solid;width:7%;vertical-align:bottom;">(Note)</td><td style="width:1%;"> </td><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;">Rate</td><td colspan="2" style="width:2%;"> </td><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;">(stated)</td><td style="width:1%;"> </td><td style="BORDER-BOTTOM: 1px solid;width:8%;vertical-align:bottom;">Conversion</td><td style="width:1%;"> </td></tr><tr style="height:15px"><td style="width:28%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td colspan="2" style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:7%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td colspan="2" style="width:2%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G. (1)</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/23/2006</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:bottom;">€</td><td style="width:6%;vertical-align:bottom;">182</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.10</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Anglo Irish Bank S.A.(3)</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">10/21/2007</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">500</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.50</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4090</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">12/10/2007</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">1,500</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.50</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4429</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">01/22/2008</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">1,500</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.50</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4629</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">04/25/2008</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">2,000</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.50</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.5889</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/30/2008</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">1,500</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.50</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.5380</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">11/18/2008</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">1,200</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.50</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2650</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">02/09/2009</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">1,500</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.50</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2940</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/15/2009</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">5,500</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2,4</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.80</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4045</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/15/2009</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">100</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2,4</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.80</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4300</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Von Meyenburg</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">08/03/2009</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">200</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.80</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4400</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">10/13/2009</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">2,000</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">5% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.25</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4854</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">12/18/2009</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">2,200</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(2</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">5% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.25</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.4338</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">08/04/2011</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">1,148</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(5,6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">08/04/2011</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">297</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(5,6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:bottom;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">11/08/2011</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">400</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3787</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">11/08/2011</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">100</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3787</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">02/10/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">1,000</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3260</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">02/14/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">200</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3260</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">04/19/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">322</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3100</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">04/19/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">80</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3100</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">05/04/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">480</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3152</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">05/04/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">120</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3152</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">09/03/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">200</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2576</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">09/03/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">50</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2576</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">11/14/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">500</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2718</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">12/06/2012</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">125</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3070</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">01/16/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">240</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3318</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">01/16/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">60</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3318</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">03/25/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">400</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.037</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2915</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">04/14/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">150</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3056</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">04/14/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">600</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.034</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3056</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">05/15/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">170</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.037</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2938</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">05/15/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">680</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.037</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.2938</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/24/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">60</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.025</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3340</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/24/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">240</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.025</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3340</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">08/05/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">80</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.018</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3283</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">08/05/2013</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">320</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(6</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">10% pa</td><td style="width:1%;"> </td><td style="width:1%;vertical-align:bottom;">$</td><td style="width:8%;vertical-align:top;">0.018</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">1.3283</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">03/01/2017</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">230</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(7</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">03/01/2017</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">920</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(7</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">10/18/2017</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">230</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(7</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">10/18/2017</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">920</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(7</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/01/2018</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">160</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(8</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">06/01/2018</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">640</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(8</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">11/10/2018</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">160</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(8</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">11/10/2018</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">640</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:bottom;">(8</td><td style="width:1%;vertical-align:bottom;">)</td><td style="width:8%;vertical-align:bottom;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:bottom;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">06/15/2019</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">120</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(9</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">06/15/2019</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">480</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(9</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:top;">Eardley Holding A.G.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">12/20/2019</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">120</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(10</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">12/20/2019</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">480</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(10</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:top;">Eardley Holding AG</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">06/15/2020</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">220</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(11</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">06/15/2020</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">880</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(11</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:top;">Eardley Holding AG</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">12/15/2020</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">170</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(12</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">12/15/2020</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">680</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(12</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:top;">Eardley Holding AG</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">08/15/2021</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">240</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(13</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">08/15/2021</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">960</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(13</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:top;">Eardley Holding AG</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">04/30/2022</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:top;">120</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(14</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:top;">Round Enterprises Ltd.</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">04/30/2022</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="BORDER-BOTTOM: 1px solid;width:2%;vertical-align:top;">€</td><td style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:top;">480</td><td style="width:1%;"> </td><td style="width:7%;vertical-align:top;">(14</td><td style="width:1%;vertical-align:top;">)</td><td style="width:8%;vertical-align:top;">2.5% pa</td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td><td style="width:8%;vertical-align:top;">N/A</td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">Total Short Term Principal Amounts</td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:2%;vertical-align:top;">€</td><td style="width:6%;vertical-align:bottom;">36,744</td><td style="width:1%;"> </td><td style="width:7%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:28%;vertical-align:bottom;">Accrued Interest</td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="BORDER-BOTTOM: 1px solid;width:2%;vertical-align:top;">€</td><td style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;">32,787</td><td style="width:1%;"> </td><td style="width:7%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:28%;vertical-align:bottom;">TOTAL LOANS AND NOTES</td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="BORDER-BOTTOM: 3px double;width:2%;vertical-align:top;">€</td><td style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;">69,531</td><td style="width:1%;"> </td><td style="width:7%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td><td style="width:8%;"> </td><td style="width:1%;"> </td></tr></tbody></table>

06/23/2006

182000

0.10

10/21/2007

500000

0.10

0.50

1.4090

12/10/2007

1500000

0.10

0.50

1.4429

01/22/2008

1500000

0.10

0.50

1.4629

04/25/2008

2000000

0.10

0.50

1.5889

06/30/2008

1500000

0.10

0.50

1.5380

11/18/2008

1200000

0.10

0.50

1.2650

02/09/2009

1500000

0.10

0.50

1.2940

06/15/2009

5500000

0.10

0.80

1.4045

06/15/2009

100000

0.10

0.80

1.4300

08/03/2009

200000

0.10

0.80

1.4400

10/13/2009

2000000

0.05

0.25

1.4854

12/18/2009

2200000

0.05

0.25

1.4338

08/04/2011

1148000

0.10

0.034

08/04/2011

297000

0.10

0.034

11/08/2011

400000

0.10

0.034

1.3787

11/08/2011

100000

0.10

0.034

1.3787

02/10/2012

1000000

0.10

0.034

1.3260

02/14/2012

200000

0.10

0.034

1.3260

04/19/2012

322000

0.10

0.034

1.3100

04/19/2012

80000

0.10

0.034

1.3100

05/04/2012

480000

0.10

0.034

1.3152

05/04/2012

120000

0.10

0.034

1.3152

09/03/2012

200000

0.10

0.034

1.2576

09/03/2012

50000

0.10

0.034

1.2576

11/14/2012

500000

0.10

0.034

1.2718

12/06/2012

125000

0.10

0.034

1.3070

01/16/2013

240000

0.10

0.034

1.3318

01/16/2013

60000

0.10

0.034

1.3318

03/25/2013

400000

0.10

0.037

1.2915

04/14/2013

150000

0.10

0.034

1.3056

04/14/2013

600000

0.10

0.034

1.3056

05/15/2013

170000

0.10

0.037

1.2938

05/15/2013

680000

0.10

0.037

1.2938

06/24/2013

60000

0.10

0.025

1.3340

06/24/2013

240000

0.10

0.025

1.3340

08/05/2013

80000

0.10

0.018

1.3283

08/05/2013

320000

0.10

0.018

1.3283

03/01/2017

230000

0.025

03/01/2017

920000

0.025

10/18/2017

230000

0.025

10/18/2017

920000

0.025

06/01/2018

160000

0.025

06/01/2018

640000

0.025

11/10/2018

160000

0.025

11/10/2018

640000

0.025

06/15/2019

120000

0.025

06/15/2019

480000

0.025

12/20/2019

120000

0.025

12/20/2019

480000

0.025

06/15/2020

220000

0.025

06/15/2020

880000

0.025

12/15/2020

170000

0.025

12/15/2020

680000

0.025

08/15/2021

240000

0.025

08/15/2021

960000

0.025

04/30/2022

120000

0.025

04/30/2022

480000

0.025

36744000

32787000

69531000

190000 1200000 300000 reducing by 10% the price per share of the Company’s common stock paid by the investors in connection with an investment in the Company of not less than US$20,000, or (ii) at the fixed conversion price using a fixed exchange rate which are noted in the table above 1840000 460000

0.025

The first 50% of the promissory Notes of €920 and €230, respectively, were provided immediately. The second 50% of the promissory notes of €920 and €230, respectively, were provided on October 18, 2017, with a 2.5% interest per annum and a maturity date of October 18, 2018

1280000 320000

0.025

The first tranche of the promissory Notes of €640 and €160, respectively, were provided immediately. The second tranche of the promissory notes of €640 and €160, respectively, were provided on November 10, 2018, with a 2.5% interest per annum.

600000

0.025

The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

600000

0.025

The promissory Notes of €480 and €120, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) June 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

1100000

0.025

The promissory Notes of €880 and €220, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) September 30, 2020, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

850000

0.025

The promissory Notes of €680 and €170, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) March 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

1200000

0.025

The promissory Notes of €960 and €240, respectively, were provided immediately. The maturity date of these promissory notes to follow the same terms of other convertible loans and is the later of (i) December 31, 2021, or (ii) the end of a subsequent calendar quarter in which the Company receives a written request from the lender for repayment of the unpaid principal and accrued interest due under the Notes.

960000 240000

0.025

The first tranche of the promissory Notes of €480 and €120, respectively, were provided immediately. The second tranche of the promissory notes of €480 and €120, respectively, will be provided in August, 2022, with a 2.5% interest per annum.

156000

A first amortization installment of €28 will be due on September 30, 2022. This installment is related to the period of March to September 2022. The next amortization of €14 will be due on March 31, 2023. The entire loan should be fully amortized by September 30, 2027.

Note 3. Commitments The facility lease agreement for Epalinges, Switzerland, is automatically renewed month by month with a notice period of three months. The related rent is paid monthly in the amount of €4 and is considered a short-term lease. As the term is less than twelve months, the lease is outside of the scope of ASC 842 and not accounted for on the balance sheet due to the Company’s policy elections. The facility lease agreement for Leiden, The Netherlands, runs until March 31, 2024, and can be terminated with a six month notice as of September 30, 2023. The related rent is paid monthly in the amount of €9. The Company does not have any other operating lease for its research and development facilities, corporate headquarter, offices and equipment.

4000

9000

Note 4. Subsequent Events None

EXCEL 27 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 28 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 29 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 30 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 194 169 1 false 68 0 false 5 false false R1.htm 000001 - Document - Cover Sheet http://mymx.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://mymx.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) Sheet http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) Statements 4 false false R5.htm 000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED) Sheet http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED) Statements 5 false false R6.htm 000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 6 false false R7.htm 000007 - Disclosure - The Company and Summary of Significant Accounting Policies Sheet http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPolicies The Company and Summary of Significant Accounting Policies Notes 7 false false R8.htm 000008 - Disclosure - Debt Financing Sheet http://mymx.com/role/DebtFinancing Debt Financing Notes 8 false false R9.htm 000009 - Disclosure - Commitments Sheet http://mymx.com/role/Commitments Commitments Notes 9 false false R10.htm 000010 - Disclosure - Subsequent Events Sheet http://mymx.com/role/SubsequentEvents Subsequent Events Notes 10 false false R11.htm 000011 - Disclosure - The Company and Summary of Significant Accounting Policies (Policies) Sheet http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies The Company and Summary of Significant Accounting Policies (Policies) Policies http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPolicies 11 false false R12.htm 000012 - Disclosure - Debt Financing (Tables) Sheet http://mymx.com/role/DebtFinancingTables Debt Financing (Tables) Tables http://mymx.com/role/DebtFinancing 12 false false R13.htm 000013 - Disclosure - The Company and Summary of Significant Accounting Policies (Details Narrative) Sheet http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative The Company and Summary of Significant Accounting Policies (Details Narrative) Details http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies 13 false false R14.htm 000014 - Disclosure - Debt Financing (Details) Sheet http://mymx.com/role/DebtFinancingDetails Debt Financing (Details) Details http://mymx.com/role/DebtFinancingTables 14 false false R15.htm 000015 - Disclosure - Debt Financing (Details Narrative) Sheet http://mymx.com/role/DebtFinancingDetailsNarrative Debt Financing (Details Narrative) Details http://mymx.com/role/DebtFinancingTables 15 false false R16.htm 000016 - Disclosure - Commitments (Details Narrative) Sheet http://mymx.com/role/CommitmentsDetailsNarrative Commitments (Details Narrative) Details http://mymx.com/role/Commitments 16 false false All Reports Book All Reports mymx_10q.htm mymx-20220630.xsd mymx-20220630_cal.xml mymx-20220630_def.xml mymx-20220630_lab.xml mymx-20220630_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 33 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "mymx_10q.htm": { "axisCustom": 0, "axisStandard": 5, "contextCount": 194, "dts": { "calculationLink": { "local": [ "mymx-20220630_cal.xml" ] }, "definitionLink": { "local": [ "mymx-20220630_def.xml" ] }, "inline": { "local": [ "mymx_10q.htm" ] }, "labelLink": { "local": [ "mymx-20220630_lab.xml" ] }, "presentationLink": { "local": [ "mymx-20220630_pre.xml" ] }, "schema": { "local": [ "mymx-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 272, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 13, "http://mymx.com/20220630": 4, "http://xbrl.sec.gov/dei/2022": 5, "total": 22 }, "keyCustom": 34, "keyStandard": 135, "memberCustom": 64, "memberStandard": 4, "nsprefix": "mymx", "nsuri": "http://mymx.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "strong", "span", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://mymx.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "strong", "span", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000010 - Disclosure - Subsequent Events", "role": "http://mymx.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000011 - Disclosure - The Company and Summary of Significant Accounting Policies (Policies)", "role": "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "The Company and Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000012 - Disclosure - Debt Financing (Tables)", "role": "http://mymx.com/role/DebtFinancingTables", "shortName": "Debt Financing (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "EUR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000013 - Disclosure - The Company and Summary of Significant Accounting Policies (Details Narrative)", "role": "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "The Company and Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "0", "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtDefaultShorttermDebtAmount", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000014 - Disclosure - Debt Financing (Details)", "role": "http://mymx.com/role/DebtFinancingDetails", "shortName": "Debt Financing (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtDefaultShorttermDebtAmount", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ServicingAssetAtAmortizedValueRiskCharacteristicsDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000015 - Disclosure - Debt Financing (Details Narrative)", "role": "http://mymx.com/role/DebtFinancingDetailsNarrative", "shortName": "Debt Financing (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ServicingAssetAtAmortizedValueRiskCharacteristicsDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30_mymx_SwitzerlandsMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsForRent", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000016 - Disclosure - Commitments (Details Narrative)", "role": "http://mymx.com/role/CommitmentsDetailsNarrative", "shortName": "Commitments (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30_mymx_SwitzerlandsMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsForRent", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "role": "http://mymx.com/role/CondensedConsolidatedBalanceSheets", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)", "role": "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-04-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED)", "role": "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": "-3", "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "role": "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "EUR", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000007 - Disclosure - The Company and Summary of Significant Accounting Policies", "role": "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPolicies", "shortName": "The Company and Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000008 - Disclosure - Debt Financing", "role": "http://mymx.com/role/DebtFinancing", "shortName": "Debt Financing", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000009 - Disclosure - Commitments", "role": "http://mymx.com/role/Commitments", "shortName": "Commitments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mymx_10q.htm", "contextRef": "From2022-01-01to2022-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 68, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line 2" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address Address Line 3" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Security 12g Title" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://mymx.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "mymx_BasicAndDilutiveEarningsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and dilutive earnings per share" } } }, "localname": "BasicAndDilutiveEarningsPerShare", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "perShareItemType" }, "mymx_BasicWeightedAndDilutedNumberOfShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic weighted and diluted" } } }, "localname": "BasicWeightedAndDilutedNumberOfShare", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "mymx_CarryingAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Carrying amount" } } }, "localname": "CarryingAmount", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_CoronavirusAidReliefAndEconomicSecurityActPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CORONAVIRUS AID, RELIEF AND ECONOMIC SECURITY ACT" } } }, "localname": "CoronavirusAidReliefAndEconomicSecurityActPolicyTextBlock", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mymx_DebtInstrumentFaceValue1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt instrument face value 1" } } }, "localname": "DebtInstrumentFaceValue1", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_DebtInstrumentFaceValue2": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt instrument face value 2" } } }, "localname": "DebtInstrumentFaceValue2", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_DebtInstrumentFaceValue3": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt instrument face value 3" } } }, "localname": "DebtInstrumentFaceValue3", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_DescriptionOfConversionPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of conversion price" } } }, "localname": "DescriptionOfConversionPrice", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "stringItemType" }, "mymx_DescriptionOfGrantAllocated": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Grant allocated description" } } }, "localname": "DescriptionOfGrantAllocated", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "mymx_DescriptionOfOverallBudget": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Budget description" } } }, "localname": "DescriptionOfOverallBudget", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "mymx_ExceedCurrentLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Current liabilities exceeding current assets" } } }, "localname": "ExceedCurrentLiabilities", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_FirstYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "First Year [Member]" } } }, "localname": "FirstYearMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_GrantRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Grant Revenue [Member]" } } }, "localname": "GrantRevenueMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_Grants": { "auth_ref": [], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 3.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Grants" } } }, "localname": "Grants", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "mymx_ImpactOfNovelCoronavirusPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IMPACT OF THE NOVEL CORONAVIRUS" } } }, "localname": "ImpactOfNovelCoronavirusPolicyTextBlock", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mymx_IncomeTaxProvision": { "auth_ref": [], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Income tax provision]", "negatedLabel": "Income tax provision" } } }, "localname": "IncomeTaxProvision", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "mymx_IncreaseDecreaseInOtherInterestPayableNet": { "auth_ref": [], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accrued interest on non-convertible notes payable" } } }, "localname": "IncreaseDecreaseInOtherInterestPayableNet", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "mymx_IssuanceDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the debt instrument was issued, in CCYY-MM-DD format.", "label": "Issuance date" } } }, "localname": "IssuanceDate", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "stringItemType" }, "mymx_NationalInstitutesOfHealth": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NIH" } } }, "localname": "NationalInstitutesOfHealth", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mymx_NetharlandsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Netherlands [Member]" } } }, "localname": "NetharlandsMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_NoteEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 8 [Member]" } } }, "localname": "NoteEightMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteEighteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 18 [Member]" } } }, "localname": "NoteEighteenMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteElevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 11 [Member]" } } }, "localname": "NoteElevenMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 15 [Member]" } } }, "localname": "NoteFiftteenMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 55 [Member]" } } }, "localname": "NoteFiftyFiveMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 54 [Member]" } } }, "localname": "NoteFiftyFourMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 50 [Member]" } } }, "localname": "NoteFiftyMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 51 [Member]" } } }, "localname": "NoteFiftyOneMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 53 [Member]" } } }, "localname": "NoteFiftyThreeMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiftyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 52 [Member]" } } }, "localname": "NoteFiftyTwoMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFifySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 57 [Member]" } } }, "localname": "NoteFifySevenMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFifySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 56 [Member]" } } }, "localname": "NoteFifySixMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 5 [Member]" } } }, "localname": "NoteFiveMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 48 [Member]" } } }, "localname": "NoteFortyEightMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 45 [Member]" } } }, "localname": "NoteFortyFiveMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 44 [Member]" } } }, "localname": "NoteFortyFourMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 40 [Member]" } } }, "localname": "NoteFortyMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 49 [Member]" } } }, "localname": "NoteFortyNineMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 41 [Member]" } } }, "localname": "NoteFortyOneMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 47 [Member]" } } }, "localname": "NoteFortySevenMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 46 [Member]" } } }, "localname": "NoteFortySixMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 43 [Member]" } } }, "localname": "NoteFortyThreeMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFortyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 42 [Member]" } } }, "localname": "NoteFortyTwoMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 4 [Member]" } } }, "localname": "NoteFourMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteFourteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 14 [Member]" } } }, "localname": "NoteFourteenMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 9 [Member]" } } }, "localname": "NoteNineMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteNinteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 19 [Member]" } } }, "localname": "NoteNinteenMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 1 [Member]" } } }, "localname": "NoteOneMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails", "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_NoteSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 7 [Member]" } } }, "localname": "NoteSevenMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteSeventeenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 17 [Member]" } } }, "localname": "NoteSeventeenMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 6 [Member]" } } }, "localname": "NoteSixMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteSixteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 16 [Member]" } } }, "localname": "NoteSixteenMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 10 [Member]" } } }, "localname": "NoteTenMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThirteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 13 [Member]" } } }, "localname": "NoteThirteenMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 3 [Member]" } } }, "localname": "NoteThreeMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 38 [Member]" } } }, "localname": "NoteThrityEightMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 35 [Member]" } } }, "localname": "NoteThrityFiveMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 34 [Member]" } } }, "localname": "NoteThrityFourMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 30 [Member]" } } }, "localname": "NoteThrityMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 39 [Member]" } } }, "localname": "NoteThrityNineMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 31 [Member]" } } }, "localname": "NoteThrityOneMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThritySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 37 [Member]" } } }, "localname": "NoteThritySevenMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThritySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 36 [Member]" } } }, "localname": "NoteThritySixMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 33 [Member]" } } }, "localname": "NoteThrityThreeMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteThrityTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 32 [Member]" } } }, "localname": "NoteThrityTwoMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 28 [Member]" } } }, "localname": "NoteTwentyEightMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 25 [Member]" } } }, "localname": "NoteTwentyFiveMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 24 [Member]" } } }, "localname": "NoteTwentyFourMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 20 [Member]" } } }, "localname": "NoteTwentyMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 29 [Member]" } } }, "localname": "NoteTwentyNineMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 21 [Member]" } } }, "localname": "NoteTwentyOneMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 27 [Member]" } } }, "localname": "NoteTwentySevenMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 26 [Member]" } } }, "localname": "NoteTwentySixMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 23 [Member]" } } }, "localname": "NoteTwentyThreeMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 22 [Member]" } } }, "localname": "NoteTwentyTwoMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwevleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 12 [Member]" } } }, "localname": "NoteTwevleMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_NoteTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Note 2 [Member]" } } }, "localname": "NoteTwoMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "domainItemType" }, "mymx_PromissoryNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory Notes" } } }, "localname": "PromissoryNotes", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_PromissoryNotes1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory Notes 1" } } }, "localname": "PromissoryNotes1", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_PromissoryNotes2": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory Notes 2" } } }, "localname": "PromissoryNotes2", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_PromissoryNotesEardleyHoldingAg": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory Notes Eardley Holding AG" } } }, "localname": "PromissoryNotesEardleyHoldingAg", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_PromissoryNotesRoundEnterprisesLtd": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory Notes Round Enterprises" } } }, "localname": "PromissoryNotesRoundEnterprisesLtd", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_PromissoryNotesTranches1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory Notes Tranches 1" } } }, "localname": "PromissoryNotesTranches1", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_PromissoryNotesTranches2": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Promissory Notes Tranches 2" } } }, "localname": "PromissoryNotesTranches2", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_ReceivedFromFederalCreditLine": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Received from federal credit line" } } }, "localname": "ReceivedFromFederalCreditLine", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_RelatedPartyTransactionsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsPolicyTextBlock", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "mymx_SecondYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Second Year [Member]" } } }, "localname": "SecondYearMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Option [Member]" } } }, "localname": "StockOptionsMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_SubAwardGrantRevenueEuro": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Sub award grant revenue euro" } } }, "localname": "SubAwardGrantRevenueEuro", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_SubAwardGrantRevenueUSDollar": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Sub award grant revenue USD" } } }, "localname": "SubAwardGrantRevenueUSDollar", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_SubAwardProjectCostEuro": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Sub award project cost euro" } } }, "localname": "SubAwardProjectCostEuro", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_SubAwardProjectCostUSDollar": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Sub award project cost USD" } } }, "localname": "SubAwardProjectCostUSDollar", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "mymx_SwitzerlandsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Switzerlands [Member]" } } }, "localname": "SwitzerlandsMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_ThirdYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Third Year [Member]" } } }, "localname": "ThirdYearMember", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "mymx_TranslationAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Translation adjustment" } } }, "localname": "TranslationAdjustment", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "mymx_WeightedAverageNumberOfSharesContingentlyConvertibleLoans": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Potentially shares issuable convertible loans" } } }, "localname": "WeightedAverageNumberOfSharesContingentlyConvertibleLoans", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "mymx_WeightedAverageSharesOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted-average shares outstanding, basic and diluted" } } }, "localname": "WeightedAverageSharesOutstandingBasicAndDiluted", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "sharesItemType" }, "mymx_WithholdingTaxesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WITHHOLDING TAXES" } } }, "localname": "WithholdingTaxesPolicyTextBlock", "nsuri": "http://mymx.com/20220630", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r38", "r40", "r82", "r83", "r174", "r205" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://mymx.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r39", "r40", "r82", "r83", "r174", "r205" ], "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://mymx.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "The Company and Summary of Significant Accounting Policies" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r30", "r289" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r131", "r132" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r10", "r152" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Property and equipment, accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r23", "r43", "r44", "r45", "r312", "r325", "r326" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r42", "r45", "r52", "r53", "r54", "r86", "r87", "r88", "r255", "r285", "r321", "r322" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r21", "r289" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 21.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r86", "r87", "r88", "r235", "r236", "r237", "r261" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "APIC" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r13", "r80", "r117", "r120", "r126", "r140", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r250", "r256", "r268", "r287", "r289", "r297", "r311" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets]", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r28", "r80", "r140", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r250", "r256", "r268", "r287", "r289" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets, Current]", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "BASIS OF PRESENTATION AND GOING CONCERN" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r9", "r289", "r328", "r329" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "[Cash]", "periodEndLabel": "Cash, end of period", "periodStartLabel": "Cash, beginning of period" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "CASH" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r66", "r269" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect]", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r9" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r36", "r301", "r316" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies (Note 3)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r155", "r156", "r157", "r158", "r333" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Note 3. Commitments" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/Commitments" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r86", "r87", "r261" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r20", "r206" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r20", "r289" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 23.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, U.S. $0.01 par value; 1,200,000,000 shares authorized; issued and outstanding 303,757,622 at June 30, 2022 and at December 31, 2021" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r47", "r49", "r50", "r59", "r304", "r318" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "[Comprehensive Income (Loss), Net of Tax, Attributable to Parent]", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r108", "r109", "r130", "r266", "r267", "r327", "r332" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r105", "r309" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r108", "r109", "r130", "r266", "r267" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r108", "r109", "r130", "r266", "r267", "r332" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r75", "r252" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "PRINCIPLES OF CONSOLIDATION" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r32" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible notes payable and related accrued interest to related parties" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r60" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 7.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "[Costs and Expenses]", "totalLabel": "Total Expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_DebtDefaultShorttermDebtAmount": { "auth_ref": [ "r78" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of outstanding short-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured.", "label": "Total short term principal amounts" } } }, "localname": "DebtDefaultShorttermDebtAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Financing" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r78", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r187", "r194", "r195", "r196", "r202" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Note 2. Debt Financing" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancing" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAnnualPrincipalPayment": { "auth_ref": [ "r16" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the total principal payments made during the annual reporting period.", "label": "Principal amount" } } }, "localname": "DebtInstrumentAnnualPrincipalPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r14", "r15", "r16", "r79", "r84", "r170", "r171", "r172", "r173", "r174", "r175", "r177", "r183", "r184", "r185", "r186", "r188", "r189", "r190", "r191", "r192", "r193", "r198", "r199", "r200", "r201", "r281", "r298", "r299", "r310" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails", "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r172", "r197" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Conversion price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentDescription": { "auth_ref": [ "r14", "r16", "r207", "r298", "r299", "r308", "r310" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.", "label": "Debt instruments description" } } }, "localname": "DebtInstrumentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r185", "r198", "r199", "r265" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Total loans and notes", "verboseLabel": "Total loans and notes" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails", "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r79" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Accrued interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r34", "r171" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r35", "r79", "r84", "r170", "r171", "r172", "r173", "r174", "r175", "r177", "r183", "r184", "r185", "r186", "r188", "r189", "r190", "r191", "r192", "r193", "r198", "r199", "r200", "r201", "r281" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails", "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r18" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssetsNoncurrent": { "auth_ref": [ "r12" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.", "label": "Rent deposit" } } }, "localname": "DepositsAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r71", "r151" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r100", "r101" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "EARNINGS PER SHARE" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r269" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 13.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect on foreign exchange rate on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r52", "r53", "r54", "r86", "r87", "r88", "r90", "r95", "r97", "r102", "r141", "r206", "r208", "r235", "r236", "r237", "r247", "r248", "r261", "r270", "r271", "r272", "r273", "r274", "r275", "r285", "r321", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r263", "r264" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "FAIR VALUES OF FINANCIAL INSTRUMENTS" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "auth_ref": [ "r276", "r277" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.", "label": "Fixed rate conversion" } } }, "localname": "ForeignCurrencyExchangeRateTranslation1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetails" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "FOREIGN CURRENCY TRANSLATION" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r11", "r144", "r145", "r146", "r148", "r289", "r296" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r147", "r148", "r149" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "GOODWILL" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r150", "r154" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "IMPAIRMENT OF LONG LIVED ASSETS" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r57", "r117", "r119", "r122", "r125", "r127", "r295", "r302", "r306", "r319" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 13.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]", "totalLabel": "Loss before income tax provision" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r51", "r241", "r242", "r243", "r244", "r245", "r246" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "TAXES ON INCOME" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r67", "r74" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "[Income Taxes Paid]", "negatedLabel": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r70" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "[Increase (Decrease) in Accounts Payable]", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r70" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Accrued interest on convertible notes payable" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherDeferredLiability": { "auth_ref": [ "r70" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred obligations classified as other.", "label": "Deferred grant" } } }, "localname": "IncreaseDecreaseInOtherDeferredLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "auth_ref": [ "r70" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.", "label": "[Increase (Decrease) in Prepaid Expenses, Other]", "negatedLabel": "Other" } } }, "localname": "IncreaseDecreaseInPrepaidExpensesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInReceivables": { "auth_ref": [ "r70" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.", "label": "[Increase (Decrease) in Receivables]", "negatedLabel": "Receivables" } } }, "localname": "IncreaseDecreaseInReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r55", "r116", "r279", "r280", "r305" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 10.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentInterestRate": { "auth_ref": [ "r138", "r139" ], "lang": { "en-us": { "role": { "documentation": "Rate of interest on investment.", "label": "[Investment Interest Rate]", "verboseLabel": "Interest rate" } } }, "localname": "InvestmentInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "LEASES" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r31", "r80", "r121", "r140", "r159", "r160", "r161", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r251", "r256", "r257", "r268", "r287", "r288" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "[Liabilities]", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r26", "r80", "r140", "r268", "r289", "r300", "r314" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "[Liabilities and Equity]", "totalLabel": "Total liabilities and shareholders' deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r5", "r33", "r80", "r140", "r159", "r160", "r161", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r251", "r256", "r257", "r268", "r287", "r288", "r289" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "[Liabilities, Current]", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r6", "r7", "r8", "r16", "r17", "r80", "r140", "r159", "r160", "r161", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r251", "r256", "r257", "r268", "r287", "r288" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "[Liabilities, Noncurrent]", "totalLabel": "Total long-term liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r16" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Debt-Principal Payable to the Federal Financing Bank" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r66" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 14.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "[Net Cash Provided by (Used in) Financing Activities]", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r66" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 15.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "[Net Cash Provided by (Used in) Investing Activities]", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r66", "r69", "r72" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 16.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "[Net Cash Provided by (Used in) Operating Activities]", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow from Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r46", "r48", "r54", "r58", "r72", "r80", "r89", "r91", "r92", "r93", "r94", "r96", "r97", "r99", "r117", "r119", "r122", "r125", "r127", "r140", "r159", "r160", "r161", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r262", "r268", "r303", "r317" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 15.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "[Net Income (Loss) Attributable to Parent]", "totalLabel": "Net Loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited", "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "NEW ACCOUNTING PRONOUNCEMENT" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r29", "r81", "r286" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Non-convertible notes payable and related accrued interest to related parties" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r117", "r119", "r122", "r125", "r127" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 11.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "[Operating Income (Loss)]", "totalLabel": "Operating Loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r283" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability Current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r283" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liability" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r282" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right-of-Use Asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r2", "r85", "r113", "r260" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.", "label": "Note 1. The Company and Summary of Significant Accounting Policies" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r41" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 14.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive income" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherGeneralAndAdministrativeExpense": { "auth_ref": [ "r61" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general and administrative expense classified as other.", "label": "General and administrative" } } }, "localname": "OtherGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r320" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r62" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 9.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "[Other Nonoperating Income (Expense)]", "negatedLabel": "Other (income) expense" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r68" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Rent paid per month" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CommitmentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r63" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "[Payments to Acquire Property, Plant, and Equipment]", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r19", "r204" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized", "verboseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical", "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r19", "r204" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r19", "r289" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 22.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, U.S. $0.01 par value; 5,000,000 shares authorized; none-issued or outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r3", "r27", "r142", "r143" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromFederalHomeLoanBankBorrowings": { "auth_ref": [ "r64" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from Federal Home Loan Bank (FHLBank) borrowing, classified as financing activity.", "label": "Proceeds from borrowing on-line of credit with federal bank" } } }, "localname": "ProceedsFromFederalHomeLoanBankBorrowings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r64" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from issuance of non-convertible notes" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r330", "r331" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r46", "r48", "r54", "r65", "r80", "r89", "r96", "r97", "r117", "r119", "r122", "r125", "r127", "r140", "r159", "r160", "r161", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r249", "r253", "r254", "r258", "r259", "r262", "r268", "r306" ], "calculation": { "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]", "negatedLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r153", "r289", "r307", "r315" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net of accumulated depreciation of ?480 at June 30, 2022 and ?474 at December 31, 2021" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r153", "r334", "r335" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r133", "r135", "r136", "r137" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "RECEIVABLES" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned": { "auth_ref": [ "r239", "r240" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 4.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r238", "r293", "r336" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 6.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "[Research and Development Expense]", "verboseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "RESEARCH AND DEVELOPMENT" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r22", "r208", "r289", "r313", "r324", "r326" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets", "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r86", "r87", "r88", "r90", "r95", "r97", "r141", "r235", "r236", "r237", "r247", "r248", "r261", "r321", "r323" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r76", "r77" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "REVENUE RECOGNITION" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r56", "r80", "r114", "r115", "r118", "r123", "r124", "r128", "r129", "r130", "r140", "r159", "r160", "r161", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r268", "r306" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 8.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "[Revenues]", "totalLabel": "Total revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Convertible notes, loans and contingent liabilities" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ServicingAssetAtAmortizedValueRiskCharacteristicsDescription": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "Description of the risk characteristics of the underlying financial assets for servicing assets that are subsequently measured using the amortization method.", "label": "Amortization installment description" } } }, "localname": "ServicingAssetAtAmortizedValueRiskCharacteristicsDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/DebtFinancingDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "[Shares, Issued]", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r37", "r52", "r53", "r54", "r86", "r87", "r88", "r90", "r95", "r97", "r102", "r141", "r206", "r208", "r235", "r236", "r237", "r247", "r248", "r261", "r270", "r271", "r272", "r273", "r274", "r275", "r285", "r321", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components Axis" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CommitmentsDetailsNarrative", "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited", "http://mymx.com/role/DebtFinancingDetails", "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED BALANCE SHEETS" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS DEFICIT (UNAUDITED)" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r86", "r87", "r88", "r102", "r294" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CommitmentsDetailsNarrative", "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited", "http://mymx.com/role/DebtFinancingDetails", "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r20", "r24", "r25", "r80", "r134", "r140", "r268", "r289" ], "calculation": { "http://mymx.com/role/CondensedConsolidatedBalanceSheets": { "order": 25.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "[Stockholders' Equity Attributable to Parent]", "periodEndLabel": "Balance, amount", "periodStartLabel": "Balance, amount", "totalLabel": "Total shareholders' deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets", "http://mymx.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders' Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityPolicyTextBlock": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.", "label": "PREFERRED STOCK" } } }, "localname": "StockholdersEquityPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Note 4. Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Disclosure of Cash Flow Information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r103", "r104", "r106", "r107", "r110", "r111", "r112" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "ESTIMATES" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Shares issuable for little or no cash consideration upon the satisfaction of certain conditions (contingently issuable shares) are considered outstanding common shares and included in the computation of basic Earnings Per Share as of the date that all necessary conditions have been satisfied (in essence, when issuance of the shares is no longer contingent). Outstanding common shares that are contingently returnable (that is, subject to recall) are treated in the same manner as contingently issuable shares. Contingently issuable shares include shares that (a) will be issued in the future upon the satisfaction of specified conditions, (b) have been placed in escrow and all or part must be returned if specified conditions are not met, or (c) have been issued but the holder must return all or part if specified conditions are not met. The number of contingently issuable shares is determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period.", "label": "Potentially shares issuable" } } }, "localname": "WeightedAverageNumberOfSharesContingentlyIssuable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://mymx.com/role/TheCompanyAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r113": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r149": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r157": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r158": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r202": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21459-112644" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521" }, "r278": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r291": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(d)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r337": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r338": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r339": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r341": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r85": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" } }, "version": "2.1" } ZIP 34 0001654954-22-011001-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-22-011001-xbrl.zip M4$L#!!0 ( (0X"U41%FBP& P 'MW 1 ;7EM>"TR,#(R,#8S,"YX MQ>9FHF*6: +%4L3 WL;NY32M@"E-@2 MD60&\NNO)6/C-]F\;,Y.'?MAU_;3W7I:+75+MMB''S>>:ZTQ%X31QT;[ZKIA M86HSA]#%8\,7321L0AJ6D(@ZR&44/S:V6#1^_.'O?WOX1[/Y\]/KT.HRV_

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

Date: August 11, 2022	By:	/s/ Ronald Kempers
		Chief Executive Officer

Date: August 11, 2022	By:	/s/ Ronald Kempers
		Chief Financial Officer